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INTRODUCTION 
 Until this last century ,labour pain had been exemplified as a traumatic 
and miserable event in a women’s life. Various methods have been tried since 
time immemorial to alleviate this pain. However, this endeavour did not receive 
much support till the late 19th century, because of various medical and religious 
reasons.  Labour is a complex mixture of biological mechanisms with mixed 
emotions and pain .People believed that this labour pain had lot of  biological 
significance and an  attempt to abolish it would be potentially dangerous to both 
mother and fetus and would alter uterine contractions  and prolong the delivery. 
Later  there was a breakthrough for this in 1853 “,when Sir John Snow 
anaesthetized queen  Victoria with chloroform for the delivery of her 8th baby  
prince Leopold , She later said "Dr Snow administered the blessed chloroform 
and its effect was calming and relaxing beyond measure".(1) 
 
“Childbirth has been recognized as among the most painful experiences 
known”,(melzak and his colleagues) have reported that after spending 15 years 
studying the physiology of pain, and of applying the Mc Gill Questionnaire as a 
comparative measure of the intensity of naturally occurring and artificially 
provoked pain-and the effectiveness of the technique of analgesia-they 
undertook a study on labour pain .They concluded that the pain of labour was 
the most severe they had assessed, thus making obstetrical  analgesia highly in  
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demand today. Numerous strategies either non-pharmacologic e.g., Hypnosis, 
Transcutaneous nerve stimulation, Acupuncture, Abdominal decompression, 
Yoga, parenteral drugs, Inhalational analgesics, Obstetric blocks or  epidural 
blockade are considered to tackle this pain(3). 
 Studies suggest that providing pain relief has positive impact on both mother 
and fetus and the outcome of labour.(4) 
Out of all the analgesic methods tried ACOG suggests that “Epidural block is 
the most effective and least depressant (pharmacologic option) allowing for an 
alert mother”.(5)  
Epidural analgesia is highly popular in west. In India, it’s still not much 
popularized   due to unfamiliarity, and inexpert personals.   
The mother should know well before term, how she will be accommodated 
during labour and what will be done to achieve a safe and pleasant delivery. The 
mother must be encouraged to express her preference regarding posture, 
analgesia and mobility. Fear of the un known is more dreadful than  fear of the 
known, and fear or anxiety in labour is equally as detrimental to both mother 
and fetus as is pain in labour.(6) 
The optimal analgesic is the one that can provide pan relief throughout the 
entire labour process  with no  side effects on both  mother and fetus, should 
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provide immediate onset of pain relief, effective pain relief, with minimal motor 
block, intact  airway reflexes, mother should be awake and responsive, with 
very minimal maternal and neonatal depression  and should have  no depressant 
effects on the progress of the labour and the urge to bear down. It should also 
provide some analgesia in the post partum period, and rapid recovery. (7) 
The common disadvantages of each technique of analgesia should also be 
explained to the patient: the light headness associated with inhalational 
analgesia; the clouding of consciousness and possibly increased likelihood of 
vomiting associated with pethidine; leg weakness, loss of bearing down reflex 
and increased incidence of instrumental delivery associated with epidural 
analgesia. The mothers must be told categorically that no method offers the 
certainty of complete freedom of pain. 
 Since India has poor resource setting ,if facilities for epidural blockade is not 
available or feasible or if epidural blockade is contraindicated ,we should 
consider  providing parenteral opiods ,which is still a very good option, hence  
in our study we  are analyzing  the effects of epidural analgesia in labour and  
its maternal and fetal outcome in comparision with that of  systemic opiod 
pethidine.  
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AIM OF THE STUDY 
To study the effects of epidural analgesia on labour,maternal and neonatal 
outcome. 
To compare the efficacy and side effects of epidural analgesia with that of 
intramuscular pethidine. 
OBJECTIVES OF THE STUDY 
1)To compare the efficacy of both intramuscular  pethidine and epidural 
analgesia. 
2) To compare the duration of labour in both the groups after the administration 
of the drug.  
3) To compare the normal vaginal delivery rate to instrumental  and caesarean 
delivery rate in both the groups. 
4)To compare the  maternal haemodynamic status ,maternal satisfaction and 
pain score. 
5)To compare the intrapartum and postpartum complications if any   
6) To analyze the maternal and fetal side effects in both the groups 
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 REVIEW OF LITERATURE 
HISTORY OF OBSTETRIC ANALGESICS 
Attempts to relieve labour pains started in 18th century, ancient Greeks Chinese 
and Asians tried several herbs,alcohol,hypnotism .( 8)  
INHALATIONAL TECHNIQUES 
 Civilization made a giant leap on January 19, 1847, when James Young 
Simpson used diethyl ether to anesthetize a woman with a deformed pelvis for 
delivery, barely months after the demonstration of the anaethetic effect of ether 
by Mortan in 1846. (9) In his search for a better agent,Simpson also pioneered 
the use of chloroform for obstetric pain relief.(10) 
 By 1849, the American Medical Association had recommended the use of 
analgesia in obstetrics and reported that "in all difficult and instrumental 
labours, their application could not be rightfully withheld". 
There was a strong public opinion controverting the evasion of labour pains, 
which many believed was a divine affliction ,however the turning point in the 
controversy came when John Snow administered chloroform to Queen Victoria 
for the delivery  of her child   8th  child prince Leopold  in 1853. She later said 
"Dr Snow administered the blessed chloroform and its effect was calming and 
relaxing   beyond measure"(1). 
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TRICHLOROETHYLENE AND AIR 
Trichloroethylene can be used with the help of automatic emotril inhaler. Use of 
trichloroethylene and air analgesia may not cause maternal hypoxia, but in the 
presence of fetal distress, oxygen enriched mixture should be given. Its other 
side effects are nausea and vomiting, sometimes it’s  sweet smell may be 
unpleasant and  prolonged use can lead to post partum hemorrhage. Its effects 
are cumulative and inhalation should be stopped whenever drowsiness 
appears.(11) 
METHOXYFLURANE 
Analgesia produced by methoxyflurane ceases once inhalation is stopped. Their 
common side effects are nausea and vomiting. 
NITROUS OXIDE 
 Kilkowitch in 1881 first used nitrous oxide as a labour pain analgesic .It 
became popular with the introduction of the Minnitl apparatus (1934) which 
delivered a mixture of nitrous oxide in air. In the early 1960’s the currently 
available 50:50 prepared mixture of nitrous oxide and oxygen (entonox) was 
described. Entonox can be used by the patient itself as per the need by 
intermittent inhalation, if used in the correct manner it can provide acceptable 
levels of pain relief. 
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Entonox has only 10 % of oxygen that can lead to some uneasiness. Delaying 
the start of administration until the pain is felt is a guarantee that analgesia will 
not be obtained, and is the major reason for the discontent. 
In 1983  Central Mid Wives board withdrew approval for the use of 
trichloroethylene and methoxyflurane  by unsupervised midwives thus nitrous 
oxide was only available after that.(8) 
Other agents that are currently in use are sevoflurane (Sevox), isoflurane and 
enflurane. 
 
Psychological methods  
Various psychological methods have also been attempted to alleviate the pain of 
labour. 
In the late 18th century, Mesmer promoted a form of hypnosis for reducing 
labour pain.  But this was  extremely effective in eliminating  the pain of labour 
but in a small minority of patients .The claimed incidence of success ranges 
from 23-59 % among selected subjects (moya and  james  1960(12). Other 
major draw backs associated with this technique are the requirement to spend a 
considerable time with each patient during the antenatal period and the heavy 
demands made by the hypnotized patient upon the midwifery staff. 
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ABDOMINAL DECOMPRESSION 
This practice has had occasional advocates subsequent to its initial description 
by HEYNS (1959)(13).It provided  pain relief  by  relaxation of the muscles of 
the anterior and posterior abdominal walls, thus  uterus is able to move forward 
freely during a contraction, but unfortunately its analgesic effect is very less. 
TRANS CUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) 
An electrical impulse is applied to the sensory nerves of the target organ using 
electrodes attached to the skin at appropriate sites. This has proved to be of 
some benefit during the first stage of labour, but analgesia in the second stage of 
labour is very insufficient. (Miller Jones 1980) (14) 
ACUPUNCTURE 
The limited evidence available strongly suggests that this is ineffective in 
preventing labour pains (Wallis et al 1974)(15)  
PARENTERAL NARCOTICS 
Despite controversy, physicians quickly incorporated systemic opiods into 
practice, largely because of maternal wish .Systemic opioids was in use since 
18th century . Use of parenteral methods was developed in parallel to the 
inhalational methods. 
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 Gilbert in1870 tested a combination of chloroform and morphine. In 1902, Von 
Steinbuchel used a combination of morphine and scopolamine in labour which 
makes women amnesic known as” Dammerschlaff  which means  twilight 
sleep”. It remained popular for some time, but eventually fell into disrepute 
because of neonatal asphyxia and inadequate pain relief.(16)Various workers 
have used agents like pethidine, chloral hydrate and barbiturates with varying 
degrees of success(17) 
Pethidine (meperidine), an opioid agonist, is one of the commonly used opioid . 
Its usual dose is 50 mg intramuscularly. It’s not an effective analgesic for labour 
pains(18) .Nausea , vomiting, loss of FHR variability, neonatal respiratory 
depression, are its frequent side effects.  
PENTAZOCINE  
Pentazocine which  is a partial agonist has  a few advantages over pethidine  in 
obstetric analgesia. It can be safely used as  it  rarely produces  low APGAR  
scores even in high doses, and  fetal heart rate  almost always remains  
unaffected by its use.  Nevertheless biggest disadvantage of the drug is its 
unpleasant hallucinogenic side effect and its limited pain relief. 
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 KETAMINE 
Ketamine is an N-methyl-D-aspartate (NMDA) receptor antagonist that 
produces dissociative anesthesia .Intravenous ketamine, as a sole anaesthetic for 
relief of labour pains is not safe as it may compromise the airway. Its dose is 0.5 
to 1 mg/kg or 10 mg every 2 to 5 minutes to a total of 1 mg/kg in 30 minutes 
during labour (19).its’ main side effects are hypertension, allergic reactions, and 
neonatal respiratory depression. 
BENZODIAZEPINES 
 Benzodiazepines such as diazepam (Valium), lorazepam (Ativan), and 
midazolam (Versed) can be used as sedatives in labour. But these drugs are 
found to cross the placenta (20) and side effects include hypotonicity, decreased 
activity, respiratory depression and decreased response to metabolic stress.( 21) 
Local anesthetic techniques 
 Local anesthesia gained its popularity with the advent of syringes and 
hypodermic needles. 
PARACERVICAL BLOCK 
Gellert first described the paracervical block in 1926. It is of significance in the 
early stages of labour and is an alternative technique for a pregnant woman who 
does not want or cannot receive a neuraxial block. It provides pain relief for the 
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first stage of labour. Local anesthetic is injected submucosally into the fornix of 
the vagina lateral to the cervix to block nerve transmission through the 
paracervical ganglion. Because this block does not affect somatic sensory fibers 
from the perineum, it offers no pain relief for the second stage of 
labour(22).Because of high association of  fetal heart rate deceleration  after the 
block  it’s use is markedly reduced.(baxi et al 1979)(23) 
PUDENDAL BLOCK 
Pudendal  nerves can be easily  anesthetized through a transvaginal approach, 
by injecting local anesthetic behind each sacrospinous ligament.(24) it can be 
used as an analgesic for vaginal delivery and forceps delivery ,but not useful as 
a labour analgesic. Complications from this technique are rare, but include   
anesthetic toxicity, infection, and hematoma formation. 
EPIDURAL ANALGESIA 
LUMBAR EPIDURAL BLOCK 
Epidural analgesia in labour was first described by Von Stoeckel in 1909. He 
used procaine to produce what he termed as "sacral anaesthesia'. The use of 
lumbar epidural analgesia was made possible by the description of pain 
pathways by Aburel in 1930. As early as 1901, Tuffier had attempted lumbar 
epidural analgesia. In 1906, Sellheim described the paravertebral block.  The 
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lumbar approach to the epidural space for analgesia in labour was first used by 
Graffagnino and Seyler in 1938. In the next decade, Flowers and colleagues 
recommended using continuous lumbar epidural with a catheter (25). 
Among all the techniques available, the epidural analgesia is the gold standard 
in alleviating labour pain and is safe for both the mother and the fetus (26). Use 
of low concentrations of local anaesthetics produce only selective sensory 
blockade, thereby sparing the motor fibres, thus diminishing adverse effect of 
motor blockade, their effect can be potentiated by the use of adjuvants like 
adrenaline, clonidine and opioids. Among these, opioids are the most commonly 
used.  
COMBINED SPINAL EPIDURAL (CSE) 
 This technique has gained a lot of popularity over a period of time. Since CSE 
allows  ambulation of the parturient it is also  called as WALKING EPIDURAL 
.The effect of this analgesic technique on the progress of labour and the risk of 
dystocia need to be further evaluated. Studies shows that CSE  in early labour is 
associated with rapid cervical dilatation when compared to conventional 
epidural analgesia(27) 
· ITS ADVANTAGES OVER   CONVENTIONAL EPIDURAL 
ANALGESIA- 
ü Fast onset of action(2-5min) 
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ü Immediate sacral block 
ü Less maternal and fetal drug exposure 
ü Minimal or no motor block 
ü No acute sympathetectomy 
ü Decreased incidence of failed epidural analgesia 
· DISADVANTAGES  
- Possible increased incidence of fetal bradycardia 
- Delayed verification of functioning epidural catheter 
- Increased pruritis 
CONTINOUS EPIDURAL INFUSION 
Continuous infusion has the benefit that it allows for a continuous level of 
comfort and pain relief rather than waiting for intermittent epidural top-ups. 
 
PATIENT CONTROLLED EPIDURAL ANALGESIA 
PCEA is a novel method of the drug delivery system, has several advantages, 
including the ability to reduce the drug dosage, with excellent maternal 
satisfaction and reduces the demand of monitoring staff. Analgesia is 
established by means of either a spinal or epidural block, the catheter is 
connected to the PCEA device and the patient can then self-administer further 
boluses as required. Some authors advocate a continuous infusion with patient-
controlled top-ups, whereas others suggest a bolus-only technique (28) 
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 Pathways of labour pain illustrating the nerve pathways responsible for 
pain in the various stages of labour and the types of blocks that can block nerve 
impulse transmission through these pathways to alleviate labour pain.   
( from Eltzchig HK, Lieberman ES, Camann WR: Regional anesthesia and 
analgesia for labor and delivery. N Engl J Med 348:319, 2003.) 
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ANATOMY OF EPIDURAL SPACE IN LABOUR 
DEFINITION 
First described by corning in 1901. Epidural space is a space in the bony cavity 
of the spinal canal outside the dural sac. It extends from foramen magnum to the 
coccyx communicating laterally with the paravertebral space through the 
intervertebral foramina.  
CONTENTS OF EPIDURAL SPACE  
The epidural space contains nerve roots that decussate from foramina to 
peripheral location, lymphatics, fat, areolar tissue, and blood vessels, which 
include the well organized batson venous plexus (29) 
 FAT AND AREOLAR TISSUE  
The epidural space contains fat, but since the dural sac fills the bony spinal 
canal, this is usually  just a thin transparent film of areolar tissue(30) 
EPIDURAL VEINS (31) 
These veins form a network that run in four main trunks along the space. At 
each vertebral level ,they communicate with venous rings ,with the basivertebral 
veins on the posterior aspect of each vertebral body and with the ascending and 
deep cervical ,intercostals , iliolumbar, and lateral sacral veins. They connect 
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with  the  intracranial veins above and pelvic veins below ,so that air or other 
local anaesthetic solution injected into one of them may ascend straight to brain. 
(32) 
ARTERIAL SUPPLY 
Arteries enters the epidural space at each inter vertebral foramen and supply 
spinal cord, adjacent vertebra, and ligaments. These arteries are from the 
vertebral, ascending cervical, deep cervical, intercostals and lumbar and ilio 
lumbar arteries. They anastomose with their neighbours above and below, cross 
the midline, and lie chiefly in the lateral parts of the epidural space. 
NERVE ROOTS 
31 PAIRS OF SPINAL NERVES with their dural cuffs traverse the space on 
their way to intervertebral foramina, the lower one travelling at an increasingly 
oblique angle.(30) 
EPIDURAL SPACE IN PREGNANCY  
The epidural space in pregnant patients is at a distance of about 4-5 cms from 
the skin. The distance from the postero medial border of ligamentum flavum to 
the dura mater is greatest in the second lumbar interspace ranging between 4-8 
mm. Hence an epidural needle inserted by the midline approach should enter the 
space as close to the midline as possible to maximize the distance between the 
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ligamentum flavum and the dura. 
 In pregnancy there is widening of the pelvis resulting in a head down tilt of the 
spine in the lateral position affecting the spread of drugs (33). 
In pregnancy there is high tendency for having presacral edema, making 
landmark identification more difficult. 
Hormonal changes affect vertebral ligamentous structure and may make the 
ligamentum flavum softer (34).Preganant patients do not flex their lumbar spine 
optimally, hence tuffiers’ line will move more cephalad. 
EPIDURAL VOLUME   
Epidural veins are veins of the vertebral venous plexus, which form an 
alternative pathway by which blood can reach the lower extremity. It is of 
special significance in pregnancy for compensating for the obstruction to the 
inferior venacava.(30,33) 
EPIDURAL PRESSURE  
 In non pregnant subjects lumbar epidural space pressure  is normally 1cm 
h20.In parturients  in early labour, pressure in-between contractions in the 
lateral position averages 1.63 cm h20 and rises to between 4-10 cm h20 by the 
end of the first stage, assuming supine position will increase the epidural space 
pressure by upto 50 % and this is proportional to the degree of inferior 
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venacaval obstruction. (30) 
REASONS FOR DECREASE IN LOCAL ANAESTHETIC DOSES ARE 
1) Spread of local anesthetic due to epidural venous engorgement. 
2) Pregnancy may also enhance neuronal sensitivity to local anesthetics. 
3) Decrese in epidural space volume. 
4) Increased lordosis. 
5)Hormonal and biochemical changes may be responsible for the greater 
susceptibility to neural blockade during pregnancy. 
6)During uterine contraction epidural space pressure increases. 
All these factors leads to increase in the extent of epidural block produced by a 
given dose of drugs (35,36). 
PAIN MECHANISM IN LABOUR 
PHYSIOLOGY OF PAIN 
Traditionally the labour process is subdivided into 3 stages 
1st stage-from the onset of true labour pains to complete dilatation of cervix 
upto 10 cm.  
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2nd stage-from the complete dilatation of cervix to delivery of the fetus 
3rd stage –from the delivery of the fetus to the expulsion of the placenta. 
PAIN IN THE FIRST STAGE OF LABOUR 
In first stage of labour, pain impulses arise  from the uterine contractions  which 
results  in myometrial ischemia, which eventually  causes the release of 
bradykinin, histamine, and serotonin. In addition, stretching and distention of 
the lower uterine segment and cervix may stimulate mechanoreceptors. These 
noxious impulses follow the sensory nerve fibers that accompany sympathetic 
nerve endings; they travel through the paracervical region and the hypogastric 
plexus to enter the lumbar sympathetic chain(37).These stimuli enter the spinal 
cord at the T10, T11, T12, and L1 spinal segments. Mostly patients describe this 
pain as dull in nature and of poorly localized nature. With onset of the second 
stage of labour and stretching of the perineum, Stretching and tension of the 
bladder, urethra and rectum, Stretching and tension of the ligaments and muscle 
of the pelvic cavity , somatic afferent nerve fibers transmit impulses through the 
pudendal nerve to the spinal cord at the S2, S3, and S4 levels. 
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 Distribution and intensity of laboUr pain during each stage of labor and 
delivery. In the early first stage (A), pain is referred to the T11 and T12 
dermatomes. During the late first stage (B), pain also extends to the T10 and L1 
dermatomes. In the second stage (C), in addition to the dermatomal distribution 
of late first stage, pain is also felt as pressure in the lower part of the back and 
perineum and the upper part of the legs. During the end of the second stage and 
for delivery (D), pain originates from the perineum.  (38) 
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Labour may slow down further if the perineum is anaesthetized too early in 
labour due to abolition of ‘ferguson’s reflux ‘.The afferents of this reflux arc 
come from receptors of the cervix and the vagina and pass centrally to stimulate 
oxytocin secretion from posterior pituitary. However this defect can be readily 
overcome by exogenous oxytocin infusions.(39) 
In summary, the epidural blockade appears to have no direct depressant effect 
on the uterine contractility besides abolition of the ferguson reflux. Besides if 
early blockade of sacral segments is prevented, the incidence of instrumental 
deliveries could be reduced. 
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INDICATIONS FOR EPIDURAL ANALGESIA(40) 
· Commonest indication is maternal request ,but it can be given in 
medical disorders like  
· Pre-eclampsia 
· Multiple pregnancy 
· Breech presentation for vaginal delivery 
· Diabetes mellitus 
· Respiratory disease e.g. asthma 
· Cardiovascular disease  
· Sickle cell disease 
· Premature labour 
· Prolonged labour 
· Intrauterine growth retardation 
· Anticipated instrumental delivery 
 Contraindications (40) 
1) Patient refusal  
2) Active maternal hemorrhage 
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3) Local sepsis at epidural site 
4) Septicemia as evidenced by pyrexia (above 37.5 Degree Celsius) 
5) Maternal coagulopathy (inherited or acquired) 
6) Raised intracranial pressure (not benign intracranial HT) 
7) Uncorrected hypovolemia 
8) Fetal distress.  
9) Inadequate staff to look after the mother.  
10) Fixed cardiac output state 
Relative contraindications 
1) Technical difficulties e.g. previous back surgery, kypho scoliosis, 
gross obesity 
2) Neurological disorders 
COMPLICATIONS OF EPIDURAL ANALGESIA(40) 
v MATERNAL 
IMMEDIATE 
· High or total spinal block 
· Hypotension (systolic blood pressure < 100mmHg or a decrease of 20% 
24 
 
below pre block average) 
· Urinary retention 
· Local anesthetic induced convulsions 
· Local anesthetic induced cardiac arrest 
· Vesibulocochlear dysfunction 
DELAYED 
· Postural puncture headache 
· Transient backache 
· Epidural abscess or meningitis 
· Permanent neurologic deficit (Very rare) 
· Broken cannula tip retention 
v FETAL  
IMMEDIATE 
·     Direct effect of local anesthetic-Fetal distress. 
DELAYED 
·      Neurobehavioral changes. 
HYPOTENSION: 
When epidural analgesia is given to a patient, anesthetist should cautiously 
preload the patient with ringer lactate solution (10-15 ml/kg) and avoid 
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aortocaval compression which prevents the patient from hypotension which is 
considered as one of the commonest complication associated with labour 
analgesia. Intravenous epinephrine 5-10 mg can be given to raise blood 
pressure. Recently studies backs up the use of phenyl epinephrine (41). 
DURAL PUNCTURE AND POST DURAL HEAD ACHE: 
Even though the incidence (0.2-0.7 %) shows it as a rare complication yet it has  
disturbing sequelae of post dural puncture headache that prompts the use of 
fluid intake, caffeine  judiciously. (Cammann et al) (42). However epidural 
blood patch remains the gold standard for treating this complication. 
TOTAL SPINAL BLOCK: 
The use of test dose before injecting the drug can very well prevents this 
complication and its associated sequelae such as hypotension, dyspnoea, 
unconsciousness and respiratory paralysis. Delivering 100%oxygen, positive 
pressure ventilation and aortocaval compression should be given encountering 
this situation. 
PRURITIS: 
The exact etiology is unkown yet there is a probability for the role of histamine 
release causing pruritis in epidural analgesia. Evidence shows that neuraxial 
opioid-induced pruritis mediated through central opioid receptors. 
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Opioidantagonists (e.g.naloxone) or partial agonist-antagonists (e.g. nalbuphine) 
are effective in relieving pruritis(43). 
BLOODY TAP:  
 It’s incidence is 10%.It is the epidural venous plexus distortion which occurs 
during pregnancy which causes bloody tap and with uterine contraction this gets 
aggravated. This complication can be managed by repositioning the catheter in 
an adjacent space. (44) 
BACK ACHE: 
The incidence of back ache after epidural anesthesia has varied from 14-
45%(45) . Studies have concluded that there is no statistical difference in the 
incidence of postpartum backache among women who delivered vaginally with 
or without epidural analgesia (46). 
SHIVERING: 
Incidence of shivering in obstetric analgesia ranges from 20-50% and in patients 
without epidural analgesia was just 22%, showing that an epidural induced 
peripheral vasodilatation may not be fully responsible and other reasons should 
be ruled out for back ache.(44) 
URINARY RETENTION: 
The  rapid onset of detrusor muscle relaxation following the sacral spinal action 
of opiods and local anesthetics is the reason for  urinary retention in spinal 
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anesthesia. Hence the mother should be encouraged to void regularly and if 
required intermittent catheterization should be done as well.(44) 
Other rare complications include spinal and epidural haematoma and 
neuropathy ,motor blockade which are very rare (47). 
THE ADVANTAGES OF EPIDURAL OBSTETRIC ANALGESIA: 
· PAIN RELIEF 
- It provides superior pain relief when compared to other methods of 
analgesia. 
- It provides pain relief over prolonged periods of time of varying intensity. 
- It relieves fatigue of the mother, makes delivery more comfortable. 
- It provides anesthesia for instrumental or operative deliveries. 
 
· HYPERTENSION 
Epidural analgesia prevents the sympathoadrenal over activity that is 
characteristic of preeclampsia, produces favorable hemodynamic changes and 
improves intervillous blood flow (uteroplacental circulation) (48). 
· TRIAL OF LABOUR 
 Review of studies in several 100 women with previous caesarean        sections 
suggest that epidural analgesia   does not masks the danger of scar dehiscence or 
rupture .Epidural local anesthetics  blocks the pain of uterine contraction ( 
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which is conducted by AD fibres) but not the pain of scar 
rupture,(predominantly C fibre stimulation ) thus it helps in the diagnosis of 
scar dehiscence.(49)  
· CARDIAC DISEASE 
Cardiac patients have tendency for failure during labour. Epidural analgesia can 
reduce the work load of heart caused by increased cardiac output(induced by 
pain). 
· PULMONARY DISEASE 
Epidural analgesia blunts the hyperventilation-hypoventilation cycle that occur 
during uterine contractions, thus preventing maternal respiratory alkalosis and 
prevents hypoxia to the fetus. 
· CONVERSION TO OBSTETRIC ANAESTHESIA 
For patients with epidural analgesia, if there is any need for emergency 
caesarean section like fetal distress, arrest of progress of labour or suspected 
scar dehiscence; analgesia can easily be converted to anesthesia by simply 
increasing the dose of the drug. 
· PRETERM LABOUR AND TWIN PREGNANCY 
Studies shows that neonatal outcome in preterm labour is unaltered by use of 
epidural analgesia. Labour is less stressful and delivery is less traumatic. 
Studies suggest that epidural analgesia was linked with decreased neonatal 
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morbidity among low birth weight babies. Outcome is found to be good in 
second twin in multiple pregnancy and breech presentations as in these cases 
epidural analgesia increases intervillous circulation, decreases catecholamine 
release and aids good relaxation of pelvic floor for manipulative 
procedures.(50) 
· BENEFIT IN INCORDINATE UTERINE ACTION 
By reducing the catecholamine release associated with uterine contraction, 
epidural block can improve uterine contractility and rhythmcity. 
Studies have shown that mothers who received epidural labour analgesia spent 
only less time in the delivery rooms and had decreased incidence of post partum 
depression .(51) 
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CONTROVERSIES  
· It’s a common myth that epidural analgesia  is associated with increased 
rate of caesarean deliveries, but various studies with statistical data shows 
that there is no association (52) 
· Use of epidural analgesia can prolong the duration of labour by an 
average of one hour in 1st stage and 1 hour in second stage. It’s also 
proved that labour analgesia is also associated with higher incidence of 
occipito posterior presentation, need for augmentation of labour with 
oxytocin, and higher number of instrumental deliveries. All these side 
effects can be curtailed with the use of low dose epidural infusion (53). 
· Many hospitals   withhold  epidural analgesia  during second stage of 
labour to improve a woman's ability to push and reduce the rate of 
instrumental delivery. But of late studies have shown that this does not 
result in the statistical variation in the mode of delivery and most often 
results in inadequate pain relief from patient point of view.(54)  
 
· Task force guidelines 2007 jointly issued by the ASA and the Society of 
Obstetric Anesthesiologists and Perinatologists ( SOAP) has concluded 
that epidural analgesia  can be recommended to mothers willing for 
VBAC (vaginal birth after caeserian section ). 
· Epidural analgesia causes transient FHR changes hence this  factor should 
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be considered  to prevent  inappropriate obstetric management decisions. 
This FHR abnormalities can be effectively managed by  maternal 
repositioning , oxygenation, hydration and sometimes with tocolytics.      
( 55) 
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PHARMACOLOGY 
v BUPIVACAINE (56,57)  
This amide local anaesthetic was first synthesized by ekenstorm and associates 
in 1957,and clinically by L.J.Telivuo  in 1963 
§ STRUCTURE AND CHEMISTRY: 
 
 
                
Bupivacaine has a pKa of 8.05 (highly ionized at physiologic pH) and is 95% 
protein bound; thus, it has limited transfer to the placenta when compared with 
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other local anesthetics . The rate and degree of diffusion to the placenta is 
governed by : 
    1) The degree of plasma protein binding. 
    2) The degree of ionization.  
    3) The degree of solubility. 
The umbilical vein /maternal blood ratio (UV/M) of the drug at delivery is 0.2-
0.4. The speed of onset of action of bupivacaine is marginally slower than that 
of lignocaine . Peak concentration of bupivacaine, in maternal blood occurs 10-
60 mins. 
After epidural injection Umbilical vein concentration of the drug is only about 
30% of maternal venous concentration. 
 It is metabolized primarily in the liver, hence should be careful while 
prescribing for patients with hepatic disorders. 
§ INDICATIONS AND USAGE:  
 Indicated for producing local or regional anesthesia or analgesia for all surgical 
procedures. 
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Side Effects : 
Side effects associated with  bupivacaine are  mostly systemic toxicity from 
overdose. 
§ SIGNS OF TOXICITY 
· Early signs : 
-Tinnitus, light headedness, confusion, numbness, shivering , muscle twitching 
,tremors, tonic-clonic convulsion. 
· Late signs: 
 -Unconsciousness,  generalized CNS depression, respiratory arrest . 
 
v Fentanyl (58,59) 
Fentanyl is a synthetic opiod related to the phenylpiperidines. Fentanyl  is 1000 
times more potent than meperidine and 50-100 times more potent than 
morphine.  
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§ MECHANISM OF ACTION: 
Opiods acts as agonists at stereo specific opiod receptors at presynaptic and post 
synaptic sites in the central nervous system (principally brainstem and spinal 
cord) and outside the central nervous system in peripheral tissues. The peak 
effect occurs within 3 to 5 minutes and has duration of 30 to 60 minutes.  
The principal effect of opiod receptor activation is a decrease in 
neurotransmission. This occurs largely by presynaptic inhibition of 
neurotransmitter (acetylcholine, dopamine, nor epinephrine, substance P) 
release, although post synaptic inhibition of evoked activity might also occur. 
Fentanyl placed in the epidural space may undergo uptake into epidural fat , 
systemic absorption or diffusion across into the cerebrospinal  fluid . 
Penetration of dura is considerably influenced by lipid solubility and molecular 
weight.   
After epidural administration, fentanyl blood concentration peaks in 5-10 mins.  
Fentanyl is metabolized in liver to polar active metabolites that are then 
excreted in the bile and urine. 
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§ DOSAGE AND ADMINISTATION: 
Fentanyl is available for injection as 50 microgram/ml .It is also available 
combined with droperidol as fixed 50:1 mixtures of droperidol and fentanyl  
(2.5mg of droperidol and 50microgram of fentanyl in 1 ml). 
 For labour analgesia fentanyl is usually combined with local anesthetic. The 
bolus dose is usually 50 µg. Along with local anesthetic, infusion is at a dose of 
2 µg/ml.      
§   SIDE EFFECTS:  
 Side effects  of fentanyl include: 
1. Dose related respiratory depression 
2. Nausea and vomiting. 
3. Decreased gastrointestinal motility. 
4. Delayed gastric emptying. 
5. Constipation. 
6. Urinary retention. 
7. Pruritis. 
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v PETHIDINE (60) 
Pethidine was synthesized as an atropine substitute in 1939, and has some 
actions similar to it. Though chemically unrelated to morphine, it interacts with 
opiods and its actions are blocked by naloxone. 
§ CHEMICAL STRUCTURE: 
 
 
§ MECHANISM OF ACTION:  
Pethidine exerts its analgesic effects by acting as an agonist at the mu opioid 
receptor. In addition to the opioidergic and anticholinergic effects, it has local 
anesthetic activity.  
§ DURATION OF ACTION:3-4 HOURS 
§ PEAK ONSET OF ACTION : 40 -50 minutes;  
Fetal exposure to pethidine is highest between 2 and 3 hours after maternal 
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administration. 
Pethidine is metabolized in liver with meperidinic acid as the major metabolite 
and norpethidine as the minor metabolite, both are then excreted in urine.                                                                                                              
§ DOSAGE AND ADMINISTRATION: 
50-100 MG (preferably intramuscular route) 
§ SIDE EFFECTS: 
Nausea 
Vomiting 
Dizziness  
Loss of FHR variability 
Neonatal respiratory depression, diminution of muscle tone 
Dryness of mouth 
Blurred vision 
Tachycardia 
Tremors, mydriasis, hyperreflexia, delirium, myoclonus, convulsion 
Fall in blood pressure 
The incidence of respiratory depression  and decreased muscle tone  depends on 
the dosage of the drug administered and the time of administration to the 
laboring mother. Respiratory depression is slightly higher when the dose is 75-
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150 mg and when the injection delivery interval was less than 1 hour. 
(61).Neonatal respiratory depression can be promptly reversed by the 
administration of naloxone 0.1 ml/kg intravenously to the infant with nil side 
effects.  
Studies have suggested that pethidine does not adversely affect the progress of 
labour but its efficacy as an analgesic is open to question. One of the few well 
controlled studies desingned to assess the efficacy of parenteral analgesia 
(intramuscular or intravenous pethidine ) to epidural analgesia for relief of 
labour pain universally found that epidural technique is more effective (18). 
A technique where by incremental doses of a dilute solution of pethidine are 
administered  intravenously by a patient activated system using either an 
infusion, or a syringe pump offers the prospect of a higher quality of analgesia. 
Such devices-Cardiff Palliator incorporates safety features designed to avoid 
any possibility of over dosage. Administered intravenously the drug will begin 
to exert a beneficial effect within 2-3 minutes. The advisable dose for 
intravenous infusion is 50 mg  diluted with 10 ml  of solution. It is important to 
appreciate that the central midwives board does not stipulate or restrict the 
choice of narcotic analgesic used by “unsupervised midwives”; A firm 
indication for the administration of pethidine is in the conduct of labour of a 
mother with a coagulation defect, of either therapeutic or pathological origin, 
for whom an epidural is contraindicated.  
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MATERIALS AND METHODS 
The study was conducted in the department of Obstetrics and Gynaecology 
,PSG Institute of Medical Science and Research, Coimbatore. 
STUDY DESIGN 
Prospective randomized controlled trial. 
STUDY POPULATION 
Study group consists of two groups. Each group has 100  antenatal mothers in 
labour. 
INCLUSION CRITERIA 
Singleton pregnancy with vertex presentation 
Pregnancy complicated by – hypertensive disorders of pregnancy 
                                          – Respiratory diseases 
EXCLUSION CRITERIA 
- Bleeding diathesis 
- Local and systemic sepsis 
- Central nevous system disorders 
- Previous caeserian section 
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- Multiple pregnancy 
- Mal presentations 
- History of hypersensitivity to the drug  
- Chronic musculoskeletal disease of the lumbo sacral region 
- Mother not willing to use  the drug 
DRUG USED 
  1) Inj.Bupivacaine 0.125 %    and    inj.Fentanyl 2 mcg/ml   
  2) Inj.Pethidine 50 mg . 
  
MATERIALS 
1 ST STUDY GROUP (EPIDURAL GROUP ) 
1) 18G Tuohy needle 
2) 20G epidural catheter 
3) Loss of resistance syringe  
4) 5cc, 2c and 10cc sterile syringes 
5) Hypodermic needles-no.22,23,18 
6) Cotton swabs 
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7) Sponge holding forceps 
8) Sterile gown and gloves 
9) Betadine, spirit 
10) Local anaesthetic solution 
11) Emergency kit with laryngoscope, cuffed oral endotracheal tubes, suction 
apparatus with catheter, inj.atropine, inj.adrenaline, diazepam, avil, thiopentone, 
and dopamine. 
12)Monitor that would measure ECG continuously, blood pressure, respiratory 
rate and SpO2 
2ND GROUP (PETHIDINE GROUP) 
1)2 ML SYRINGE WITH NEEDLE 
2)COTTON SWAB 
                                          METHODOLOGY 
 
· The procedure was explained to the patient and an informed written 
consent was taken. A detailed history of the patient was obtained to 
search for any contra indications and risk factors. 
·  Baseline maternal blood pressure, maternal pulse, fetal heart rate was 
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recorded before the onset of the procedure. 
·  Once the patient gets into active labour with a per vaginal examination 
showing cervical dilatation of  3cm or more, mother will be randomly 
allocated to either of the  two groups. 
 METHODOLOGY FOR EPIDURAL ANALGESIA  (1 st group ) 
 
  
Epidural        
needle 
 
An 18 guage  IV cannula will be inserted  into  the forearm and patients 
are well hydrated with fluids at the rate of 15- 20ml/kg over 30 minutes. 
·  The patient will be positioned in the left lateral position on table and 
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the back will be prepared with betadine and sterile drapes will be 
applied. 
·  A local infiltration with 2ml of 2% lignocaine will be given at the L1-
L2 or L2-L3 interspinous space. 
·  
·  An 18 gauge tuohy needle will be introduced in to the epidural space 
with the loss of resistance to air technique and a catheter will be 
threaded into the epidural space for a distance of approximately3- 5 cm.  
· A test dose with 3 ml of 2% lignocaine with 1:200000 adrenaline will 
be injected to rule out intravascular or subarachnoid placement. 
· After  confirming  catheter ‘s correct placement in the epidural space,  a 
total volume of 8 ml of 0.125 % bupivacaine with 2 mcg/ml of fentanyl   
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is administered in to the epidural space which will be followed by an 
incremental  infusion of the same drug at the rate of 8-10ml per hour  
depending on patient’s requirements. 
· During this period patients will be assessed for the vitals, uterine 
contractions and fetal heart rate every 5 minutes for 60 minutes 
following loading dose completion and every 30 minutes thereafter until 
delivery. 
· Afterwards labour will be augmented by intravenous oxytocin infusion 
as per the institutional protocol. 
· Once the contraction begins patient will be shown the visual analogue 
scale.  
46 
 
 
· Data will be collected for the intensity of pain, level of sensory 
blockade, intensity of motor blockade and possible   side effects like 
nausea, vomiting, hypotension, head ache, urinary retention, fever,FHR 
abnormalities, every 5 minutes for 60 minutes following loading dose 
completion and every 30 minutes thereafter until delivery. 
· Partogram was marked to assess the progress of labour. 
· The progress of labour is assessed with changes in cervical dilatation 
every 3 hours.   
· The time interval between the administration of epidural drug to the full 
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cervical dilatation will be noted.   
· The duration of second stage that is full dilatation of cervix to delivery 
of the baby will be documented. 
· Incidence of the instrumental delivery and caesarean section will be 
recorded and analyzed and post partum complications if any will be  
noted. 
· The baby will be immediately assessed by the consultant pediatrician 
and the APGAR score of the neonate at 1 and 5 minutes will be recorded 
and analysed. 
 
·  Any untoward incident will be documented and a deviation from the 
protocol will disqualify the data of that patient from the study. 
· Hypotension is defined as a fall in mean blood pressure more than 20% 
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from the pre-operative blood pressure or a fall in blood pressure less 
than 100 mm of Hg.   
·  Motor and sensory block and sedation and side effects including 
itching, nausea and vomiting were evaluated every 5 minutes for 60 
minutes following loading dose completion and every 30 minutes 
thereafter until delivery. 
· Motor function was assessed by asking simple questions like whether 
the patient is able to lift her legs from bed or is able to bend her knees 
and the sensory block was assessed by pin prick method. 
· Sedation was also evaluated by a five point scale (1- wide awake; 2-
drowsy;3-dozing;4-mostly sleeping;5-awakening only when aroused). 
· Intrathecal placement of the catheter can be diagnosed by hypotension, 
motor block in the legs, warm upper foot, sudden disappearance of 
labour pains(usually epidural takes 10 minutes to act). 
· Intravascular placement can be diagnosed from  patient complaints –
metallic taste in the mouth, tingling of lips,dizziness,tinnitus, Heart rate 
increases by >30 bpm with in one minute and cardiovascular collapse 
may follow. 
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2ND GROUP (PETHIDINE GROUP) 
Once the patient enters into the  active phase of labour i.e., ≥ 3 cms dilatation, 
with good uterine contractions, base line pulse, blood pressure, fetal heart rate 
are  recorded . Injection pethidine 50 mg IM was given as a single dose. Pulse 
rate, respiratory rate, blood pressure, FHR were recorded every 30 minutes, pain 
score was noted according to visual analogue scale. Partogram was marked to 
assess the progress of labour.  
OUTCOME MEASURED 
1. Change in vital parameters, fetal heart rate. 
2. Side effects of the drug.  
3. Assessment of analgesia according to visual analogue scale. 
4. Duration of labour, duration of second stage of labour, mode of delivery was 
   noted and recorded. 
5. Condition of the baby is assessed by  APGAR score at 1 minute and 5minute  
    interval after the delivery of the baby  and the need for NICU admission. 
6. Any complications during the course of labour were recorded. Patient was  
   observed for 2 hours postpartum. 
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RESULTS 
STATISTICAL ANALYSIS 
The statistical analysis was performed using the statistical software SPSS 16.0. 
Descriptive analyses were performed by the calculation of minimum, maximum 
median and percentages. The continuous variables were analyzed using the 
Mann-Whitney U test and categorical data were compared using a Pearson χ2 
test or Fisher’s exact test, depending on the data meeting assumptions.  
Significance was defined as P<0.05.  
RESULT: 
TABLE 1: AGE DISTRIBUTION OF TWO STUDY GROUPS 
 
 
Age 
Epidural  ( n=100) 
 
Pethidine( n=100) 
Frequency 
 
Frequency 
≤ 20 4 (4%) 15 (15%) 
21-30 93 (93%) 75 (75%) 
31-40 3 (3%) 10 (10%) 
Total 100 100 
 SUMMERY OF AGE 
 Epidural ( n= 100) Pethidine (n =100) 
Min 19 19 
Max 31 37 
Median 25 25 
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The Mean rank of Epidural and Pethidine group were 99.48 and 101.52 
respectively In Both groups the median age was 25. We ran a Mann-Whitney U 
test to evaluate the difference in the age distribution in two groups. Results 
showed no significant statistical difference between both the groups(U = 
4898.5, P= 0.803)  
 
 
 
 
TABLE 2:  PARITY STATUS 
Status Epidural  
(n=100) 
Pethidine 
(n=100) 
χ 2  df P value 
Primi 80 (80%) 76 (76%)  
0.466 
 
1 
 
0.495 Multi 20 (20%) 24 (24%) 
Total 100 100 
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 We used Chi-Square test for finding the difference between parity status in 
Epidural and Pethidine group. The Chi-Square value was 0.466, (P=0.495) 
showing no significant difference in the parity status.   
 
 
 
The above pie diagrams shows the distribution of parity status in two study 
groups .   
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TABLE 3: GESTATIONAL AGE  
Gestational 
Age(weeks) 
 
Group 
 
Chi-
square 
value 
df P value 
Epidural 
(n=100) 
Pethidine 
(n=100) 
36-37 8 (8%) 8 (8%)  
0.531 
 
2 
 
0.767 38-39 54 (54%) 60 (60%) 
40-41 36 (36%) 32 (32%) 
  
Chi-Square test was used  to analyze  the  difference in the gestational age 
between both Epidural and Pethidine group. Chi-Square Value was 0.531 with 
df =2, (P = 0.767) showing no statistical difference in the gestational age 
between two  groups.  
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Table 4: BOOKED  
 Epidural ( n=100) Pethidine ( n=100) 
Booked 76 (76%) 76 (76%) 
Not booked 24 (24%) 24 (24%) 
76% cases in both epidural and pethidine group were booked in PSG while 24 
% cases were booked outside. 
Table 5:  CERVICAL DILATATION AT THE TIME OF EPIDURAL 
BLOCK OR PETHIDINE 
Cervical dilatation  Epidural Pethidine 
        3 cm 3 (3%) 4 (4%) 
>3cm -  <5cm 97 (97%) 96 (96%) 
. 
 Using Fisher’s exact test, the cervical dilatation at the time of Epidural 
analgesia and Pethidine were compared. And we could not found any significant 
difference (P>0.05) between two groups. 
 
55 
 
 
 
 
 
Table 6: PULSE RATE AND BP 
 Pulse Rate Blood Pressure 
Normal Tachycardia Normal Hypotension 
Epidural 99 (99%) 1 (1%) 99 (99%) 1 (1%) 
Pethidine 100 (100%) 0 (0%) 100 (100%) 0 (0%) 
 
 Analysis was done using Fisher’s exact test. Statistical analysis showed 
(P>0.05) and (p>0.05) for pulse and blood pressure respectively after the 
administration of the drug. Hence concluding no significant difference . 
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Table 7: PAIN SCORE 
14% patients in epidural group had no pain, while there was no one in pethidine 
group without any pain. Majority of patients in epidural group had only mild 
pain (68%) while majority of patients had severe pain (55%) in pethidine 
group.32 % patients in pethidine group complained of worst possible pain while 
only 1 % patient in epidural group had the worst possible pain.  
 Table 8: PAIN SCORE                                                                                                                                               
Pain Score 
 
Group 
 
Total 
Epidural 
(n=100) 
Pethidine  
(n=100) 
No pain 14 (14%) 0 (0%) 14 
Mild 68 (68%) 3 (3%) 71 
Moderate 8 (8%) 10 (10%) 18 
Severe 9 (9%) 55 (55%) 64 
Worst Possible 1 (1%) 32 (32%) 33 
 
Chi-Square test was used to compare the difference in pain score. The chi-
Square value was 135.9, showing significantly lower (p<0.001) pain score in 
Epidural group compared to Pethidine group.  
57 
 
 
 
Table 9: USE OF OXYTOCIN 
 Epidural  
(n=100) 
Pethidine 
(n=100) 
Oxytocin 100 (100%) 100 (100%) 
 Table shows that all patients in both the groups received oxytocin for 
augmentation of labour.  
Table 10:  CTG ABNORMALITY  
 Epidural (n=100) Pethidine (n=100) 
No Abnormality 92 (92%) 84 (84%) 
Late Declaration 5 (5%) 8 (8%) 
Variable Deceleration 3 (3%) 8 (8%) 
 
Using Chi-Square test, CTG abnormalities between both the groups were 
compared. The Chi-Square value was 3.329, and (P=0.189) indicating no 
statistical significant differences. 
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Table 11: COMPLICATIONS 
I. COMPLICATIONS IN EPIDURAL GROUP 
Complications Percentage 
Nil 77 (77%) 
Dural Puncture 2 (2%) 
Fever 2 (2%) 
Head ache 4 (4%) 
Motor Blockade 2 (2%) 
Tachycardia 4 (4%) 
Urinary retention 9 (9%) 
77% of patients in epidural group had no complication during the study period. 
Incidence of Dural puncture, fever and motor blockade were 2%, incidence of 
head ache and tachycardia were 4% and 9% patients complained of urinary 
retention. 
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II. COMPLICATIONS IN PETHIDINE GROUP 
Complications Percentage 
Nil 70 (70%) 
Vomiting 30 (30%) 
  70% patients had no complications, while 30 % patients complained of 
vomiting. 
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Table 12: SEDATION: 
 Epidural( n=100) Pethidine(n=100) 
Wide awake 40 (40%) 3 (3%) 
Drowsy 54 (54%) 37 (37%) 
Dozing 0 (0%) 34 (34%) 
Mostly sleep 6 (6%) 26 (26%) 
 
Sedative effect of the drug on the mothers between two groups were compared 
Using Chi-square test, The Chi-square value was 81.51.   
(P<0.001) showing significant statistical difference, Indicating that pethidine 
had higher sedative effect when compared to epidural analgesia. 
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Table: 13 INTERVAL TO FULL DILATATIONS 
 Median 
Epidural 240 
Pethidine 240 
 
The median time interval  from administration of drug to full dilatation was 240 
minutes in both epidural and pethidine groups. We Used Mann-Whitney U test, 
for comparison, we could not found any significant difference in the time 
interval (P=0.729). (The mean rank of Epidural and Pethidine group was 99.12 
and 101.88 respectively. The Mann –Whitney U =4862.5 and P=0.729) 
 
 
 
 TABLE:14 DURATION OF SECOND STAGE LABOUR 
Duration( minutes) Epidural (n=76) Pethidine(n=75) 
       < 30 13 (17.1%) 27 (36%) 
30-60 59 (77.6%) 41 (54.6%) 
60-90 4 (5.26%) 7 (9.3%) 
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The median duration of second stage labour in Epidural and Pethidine were 30 
and 20 minutes respectively. Mann- Whitney U test was used   for comparing 
the duration of second stage labour. Results showed no significant difference 
(P=0.152) in the duration of second stage labour between two groups. (The 
mean rank of Epidural and Pethidine were 106.04 and 94.96 respectively. The 
Mann- Whitney U=44446.0 and P=0.152). 
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Table 15: MODE OF DELIVERY  
 
 Epidural (n=100) Pethidine 
(n=100) 
Normal 36 (36%) 62 (62%) 
Caesarean 26 (26%) 25 (12%) 
Vacuum 35 (35%) 12 (12%) 
Forceps 3 (3%) 1(%) 
 
Chi-Square analysis showed no significant difference in the rate of caesarean 
section between two groups (P=0.8711). Statistics showed significant difference 
in the rate of normal  vaginal delivery, indicating pethidine group had more 
number of normal vaginal delivery (62% )  with p value (P<0.001). Rate of 
instrumental deliveries was more with epidural group (38%) vs. (13%) in 
pethidine group, with significant statistical difference (P<0.001). 
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Table 16: INDICATION FOR CAESAREAN SECTION : 
 Epidural(n=26) Pethidine(n=25) 
 
Arrest of dilatation 2 (7.69%) 2(8%) 
Cephalopelvic disproportion 2 (7.69%) 6 (24%) 
Distress 6 (23.07%) 11(44%) 
Deep transverse arrest 3 (11.53%) 2(8%) 
Failed Induction 3 (11.53%) 0 (0%) 
Meconium stained liquor 3 (11.53%) 2 (8%) 
Non progression of labour 7 (26.92%) 2 (2%) 
 
 Fisher’s exact test was used to compare the indication  for caesarean  between 
two groups. We could not find any statistical significant difference. (P=0.153).  
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Table 17: PLACENTAL SEPARATION 
 
Method 
Group χ 2 df P value 
Epidural 
(n=100) 
Pethidine 
(n=100) 
 
2.405 
 
1 
 
0.121 Spontaneous 97 (97%) 92 (92%) 
Manual Removal 3 (3%) 8 (8%) 
 Chi-Square test was done to find any differences in the placental separation 
between two groups. The Chi-Square value was 2.405 with 1 df, showing no 
statistical significant difference (P =0.121).  
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Table 18: POST-PARTUM COMPLICATION  
 
 Epidural (n=100) Pethidine (n=100) 
Nil 94 (94%) 90 (90%) 
PPH 6 (6%) 10 (10%) 
 Chi-Square test was done to find whether there is any significant difference in 
the Post-Partum complications between two groups. The Chi-Square value was 
1.087 with 1 df showing no statistical significant difference (P=0.297). 
 
 
     
Table 19: APGAR 
(i) APGAR at 1 minute 
APGAR 1minute 
 
Epidural (n=100) Pethidine (n=100) 
6 2 (2%) 7 (7%) 
7 7 (7%) 15 (15%) 
8 91 (91%) 78 (78%) 
Nil
90%
PPH
10%
Post-Partum complications in Pethidine
Nil
94%
PPH
6%
Post-Partum complications in Epidural
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Analysis was done using fisher exact test ,The APGAR score  at 1minute in 
Epidural and Pethidine group showed statistically significant difference 
(P=0.0335) showing better APGAR score  for babies born after epidural 
analgesia. 
 
 
(i) APGAR at 5 minutes 
APGAR 5 minutes Epidural (n=100) Epidural (n=100) 
 
7 3 (3%) 11 (11%) 
8 6 (6%) 14 (14%) 
9 91 (91%) 75 (75%) 
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Analysis was done using fisher exact test, The APGAR score  at 5 minute also 
showed statistically significant different results. (P=0.008), showing favorable 
neonatal outcome after epidural analgesia. 
 
 
Table 20: BIRTH WEIGHT 
 Median 
Epidural (n=100) 3.2  
Pethidine (n=100) 3.2  
 We ran a Mann –Whitney U test to evaluate the difference in the birth weight 
of babies in Epidural and Pethidine group. We could not found any significant 
differences (P=0.647). (The mean rank in Epidural and Pethidine group was 
98.64 and 102.36. The Mann-Whitney U =4813.5 and P value =0.647). 
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Table 21: NICU Admission 
 Epidural (n=100) Pethidine (n=100) 
Nil 91(91%) 82 (82%) 
Admission 5 (5%) 13(13%) 
Observation 4 (4%) 5 (5%) 
Using Fisher’s exact test, we checked the comparison between the NICU 
admissions in the two groups. We could not find any significant difference 
(P=0.1165).  
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DISCUSSION 
Total number of patients enrolled for the study was 200. These 200 consecutive 
patients were alternatively assigned to either epidural analgesia or parenteral 
pethidine in their active phase of labour, thus each study group had 100 patients. 
In our study we compared efficacy and side effects of epidural analgesia in 
labour; it’s maternal and fetal effects with that of intramuscular pethidine. Main 
outcome measured were change in vital parameters, fetal heart rate, side effects 
of the drug, assessment of analgesia according to visual analogue scale, duration 
of labour, duration of second stage of labour, mode of delivery, condition of the 
baby and the need for NICU admission and any other complications. 
It’s a proved fact that epidural analgesia provides superior pain relief when 
compared to other techniques (5). But there are lots of controversies regarding 
whether it will prolong the duration of labour, increases the chance of operative 
deliveries and its disturbing side effects. 
PAIN RELIEF 
Pain is a unique parameter which varies from person to person. It’s a subjective 
phenomenon and it is difficult to measure. In our study we used visual analogue 
scale to interpret the pain. 
Sheiner E et al (18) in his study on 401 patients evaluated the efficacy of 
analgesics (epidural versus parenteral pethidine) on labour.131 women were 
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enrolled for epidural analgesia and 270 women opted for parenteral pethidine. 
Study concluded that parturients from epidural group experienced significantly 
less pain during labor as compared to those who  received pethidine (mean VAS 
scores 5.05 vs. 9.14, respectively; p<0.001)showing that  epidural provides 
better analgesia when compared to pethidine . 
Similar conclusion was given by Loughnan et al (62) in his study. 
Our study also showed similar findings  as 14% patients in epidural group had 
no pain ,while there was no one in pethidine group without any pain after the 
administration of the drug. Majority of patients in epidural group had only mild 
pain (68%) while majority of patients in pethidine group complained of  severe 
pain (55%).32 % patients in pethidine group complained of worst possible pain 
but there was only 1 % patient in epidural group who  had the worst possible 
pain. Statistical data showed significant statistical difference in the pain score 
between both the groups with (p<0.001). 
1 patient in epidural group had worst possible pain in spite of the fact that 
epidural analgesia is popular for its profound analgesic effect. Literature shows 
that inadequate pain relief can occur in 15-20% cases in epidural analgesia 
,reason being improper placement of the epidural catheter tip, migration of the 
catheter from epidural space,or due to block in the catheter .(63)    
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AGE , PARITY AND GESTATIONAL AGE  
Age, parity and gestational age were not statistically different in both the 
groups. 
CERVICAL DILATATION AT THE TIME OF EPIDURAL 
BLOCK/PARENTERAL PETHIDINE   
From our study we concluded that cervical dilatation at the time of 
administration of drug was not statistically different in two groups with p value 
of (P>0.05). 
INTERVAL FROM ADMINISTRATION OF DRUG TO FULL 
DILATATION OF CERVIX  
Loughnan et al (62)  in his study on 614 patients in labour,310 were randomly 
allocated  for intramuscular pethidine and 304 were allocated for epidural 
bupivacaine. Results showed duration of  active labour for epidural group was 
3.3 hours and for pethidine was 3.2 hours which was not statistically different. 
 
But in contrast  Halpern et al (64) found that there was no difference in the rate 
of  caesarean delivery  between patients who received  epidural analgesia or 
parenteral pethidine; Epidural patients had longer  duration of labour in 1st 
stage  of 42 minutes.(WMD, 42 minutes; 95% CI, 17-68 minutes). 
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In our study also we could not found any significant difference in the time 
interval (P=0.729). (The mean rank of Epidural and Pethidine group were 99.12 
and 101.88 respectively. The Mann –Whitney U =4862.5 and P=0.729). 
DURATION OF SECOND STAGE  
Epidural analgesia is known to prolong the second stage of labour but not all 
studies support this. According to ACOG guidelines , prolonged second stage is 
when the duration of second stage is more than 3 hours with regional analgesia 
for  primigravida and more than 2 hours in multiparous women. 
Halpern et al in his study on 2369 women in labour, who were randomly 
assigned to epidural analgesia and parenteral pethidine found that epidural 
analgesia was associated with prolonged second stage by an average of 14 
minutes.(64) 
In contrast Bofill et al (65) found no difference in the duration of first stage of 
labour in his study on hundred women in active labour with epidural analgesia 
versus narcotics. Study showed no significant differences in the length of first 
stage of labour (p value 0.54) or second stage of labour (p value 0.55). 
 In our study we compared duration of second stage of labour between two 
groups. Results showed no significant difference (P=0.152) in the duration of 
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second stage labour .(The mean rank of Epidural and Pethidine were 106.04 and 
94.96 respectively. The Mann- Whitney U=44446.0 and P=0.152). 
MODE OF DELIVERY 
INSTRUMENTAL VAGINAL DELIVERY 
Sharma et al (66) used meta –analytic technique to evaluate  epidural analgesia 
in labour. A total of 1,339 nulliparous women were  assigned to receive epidural 
analgesia while 1,364 women were assigned to receive Inravenous 
meperdine.Women who received epidural analgesia had increased incidence of 
instrumental deliveries ( p value <0.001) 
Halpern et al(64) in their study concluded that epidural technique was 
associated with higher incidence of instrumental deliveries . 
Liu and Sia et al(67) also concluded similar   finding in their meta-analysis that 
there is increased chance of instrumental delivery (OR 2.11;95%CI 0.95 to 
4.65) with no increase in caesarean section rates. 
 In our study rate of instrumental deliveries was also more with epidural group 
(38%) vs (13% ) in pethidine group ,with significant statistical difference 
(p<0.001).The major indication of instrumental delivery in Epidural group  was 
failed maternal effort ,which could be because of perineal relaxation and motor 
block. 
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CAESAEREAN DELIVERY 
Sharma et al(66) in their study on 2,703 nulliparous women (1339 in epidural 
group ,1364 in  Intravenous meperidine group) found  no difference in  
caesarean delivery rate between both groups ( p value -0.920) 
Halpern et al (64) in their study concluded that epidural analgesia was not 
associated with increased rate of caesarean section ((OR, 1.5; 95% CI, 0.81-
2.76) 
Liu and Sia et al (67) in their meta analysis concluded that epidural analgesia 
with low concentration bupivacaine infusion is not associated with an increased 
risk of caesarean delivery (OR 1.03:95% CI 0.71 to  1.48) 
 Similar findings was also reported by Ramin et al (68)  ,randomized 1330 
women of mixed parity to receive either intravenous meperidine or an epidural 
analgesic (bupivacaine and fentanyl infusion). Rate of caesarean section for 
epidural group was 9 % and for pethidine group was 5 %. 
In our study there was no significant difference in the rate of caeserian section 
between two groups (P=0.8711). 
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PLACENTAL SEPERATION 
 
Rosaeg O P et al (69) concluded that there was no  clinically important 
difference in the number of patients who had spontaneous placental separation 
or those who required manual removal of placenta between both the groups.   
In our study also there was no statistical significant differences in the placental 
separation between two groups (P =0.121). 
 
CTG ABNORMALITY  FOLLOWING  EPIDURAL ANALGESIA  
 
In our study CTG abnormality was compared   between pethidine group and 
epidural group .Statistical analysis showed no significant  difference in both the 
groups.(p value-0.189) 
Capogna et al (70) in 2001 also found  transient FHR changes occasionally 
following  labour epidurals but these changes are transient and do not cause any 
fetal morbidity .  
Cochrane data base 2004 concluded that preloading prior to traditional high 
dose local anaesthetic block may have some beneficial effects. 
Leighton BL et al (52) in 2002 also reported that analgesic method does not 
affect fetal oxygenation, neonatal pH or 5minute Apgar score.  
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FETAL AND NEONATAL OUT COME 
 
Longhnan et al (62) in their study found 3 % neonates with 5 minute APGAR  
Score less than 9 in both epidural and pethidine group showing no difference in 
the neonatal outcome between two groups. 
 
Halpern et al (64) in his study  on comparison with parenteral pethidine and 
epidural analgesia concluded that After epidural analgesia, neonates were less 
likely to have low 5-minute Apgar scores (OR, 0.38; 95% CI, 0.18-0.81) or  
need naloxone (OR, 0.24; 95% CI, 0.07-0.77). 
 
In our study   APGAR score  at 1minute and 5 minute  in Epidural and 
Pethidine group showed statistically significant difference (P= 0.0335) and 
(P=0.008) respectively ,showing better APGAR  for babies born after epidural 
analgesia. 
The need for NICU admissions were also compared . We could not find any 
significant difference (P=0.1165).  
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COMPLICATIONS 
The following studies shows complications with epidural labor analgesia as 
compared to control group: 
Side Effect 
 
Howell CJ  
(71) 
(N=184) 
Con 
Butler 
(45) 
(N=210) 
Crawford(72) 
( N=923) 
Headache 
 
- - 19.4% 
Bladder 
Dysfunction  
- - 25.8% 
Shivering 
 
- - - 
Nausea 
 
- - - 
Backache 
 
22% 85% 45% 
 
In our study 77% of patients in epidural group had no complication . Incidence 
of Dural puncture, fever and motor blockade were 2%, incidence of head ache 
and tachycardia were 4% and 9% patients complained of urinary retention. 
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SUMMARY 
This study was done in PSG Institute of Medical Science and Research  , 
Coimbatore in the Department of Obstetrics and Gynaecology . 
Primary aim of the study was to study the effect of epidural analgesia on labour, 
maternal and neonatal outcome. 
 Seconadary aim was to compare the efficacy and side effects of epidural 
analgesia and intramuscular pethidine. 
 Total number of patients enrolled for the study was 200.  These 200   
consecutive patients were alternatively assigned to epidural analgesia and 
parenteral pethidine in their active phase of labour .Thus each study group had 
100 patients .Detailed history and examination  of the patient was  done and a   
base line CTG  was taken .Once the patient gets  in to active labour she was 
randomly allocated into either epidural analgesic group or intramuscular 
pethidine group. 
Vital parameters, fetal heart rate and uterine contractions were monitored 
following  administration of the drug ,every  5 minutes for 60 minutes following 
loading dose completion and every 30 minutes thereafter until delivery. 
Labour was augmented with oxytocin and any side effects or complications 
during the study period was noted. 
The observations noted were as follows: 
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· Age, parity and gestational age were not statistically different in both the 
groups. 
· Pain score was assessed which showed significant less pain for patients in 
epidural group when compared to pethidine group  (p<0.001). 
· Cervical dilatation at the time of administration of drug was not 
statistically different   (P>0.05).  
· We could not found any significant difference (P=0.729) in the time 
interval from administration of drug to full dilatation of cervix. (The 
mean rank of Epidural and Pethidine were 99.12 and 101.88 respectively. 
The Mann –Whitney U =4862.5 and P=0.729) 
· Duration of second stage of labour was also not significantly different 
(P=0.152) in these two groups. 
· Rate of instrumental deliveries was found to be more with epidural group 
(38%) vs. (13% ) in pethidine group ,with significant statistical difference 
(p<0.001). The major indication of instrumental delivery in Epidural 
group was failed maternal effort, which could be because of perineal 
relaxation and motor block. 
· There was no significant difference in the rate of caesarean section 
between the study groups (P=0.8711). 
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· Mode of placental separation and post partum complications were not 
statistically different with (P =0.121) and (P=0.297) respectively. 
· In our study   APGAR score  at 1minute and 5 minute  in Epidural and 
Pethidine group showed statistically significant difference (P= 0.0335) 
and (P=0.008) respectively ,showing better APGAR  for babies born after 
epidural analgesia. NICU admissions in the two groups also showed no 
significant difference (P=0.1165).  
· 77% of patients in epidural group had no complication during the study 
period. Incidence of Dural puncture, fever and motor blockade were 2%, 
incidence of head ache and tachycardia were 4% and 9% patients 
complained of urinary retention. In pethidine group 30 % patients 
complained of vomiting; sedative effect of the drug  was also 
significantly more with pethidine group. 
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CONCLUSION 
Labour analgesia strives at making child birth a less traumatic and providing a 
more comfortable zone for a mother to welcome her baby .To make this 
remarkably possible we should adopt the best possible technique which yields 
excellent analgesia with minimal side effects on both mother and baby. 
The inference of our study shows that analgesia provided by lumbar epidural 
analgesia is remarkably better than parenteral pethidine, at the same time 
duration of first ,second and third stage of  labour, placental separation, post 
partum complications ,rate of caeserian delivery were all comparable between 
the two groups.      
Parenteral pethidine is still a good option for analgesia in poor resource setting 
or in conditions where epidural analgesia is contraindicated. 
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PATIENT CONSENT FORM 
I…………………………………………………………………………………
…………………… exercising my free will of choice, hereby give my consent 
to be included  as a subject in the Clinical Trial of` “Epidural analgesia  in 
labour and its outcome”. I understand that I will be given epidural analgesia / 
intramuscular pethidine for my pain relief in labour..The risks of the procedure 
and reaction to the drug   were explained by the doctor to me in detail. I was 
given the opportunity to clarify any concerns I have and I sign this consent 
voluntarily  without any inducement and give my consent for the procedure. 
 
……………………… 
Signature of the attending obstetrician          Signature of the patient 
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PROFORMA 
NAME: 
AGE: 
OBSTETRIC SCORE: 
GESTATIONAL AGE: 
PULSE: 
BLOOD PRESSURE:   
PER VAGINAL EXAMINATION FINDINGS: 
CTG: 
TIME OF ADMINISTRATION OF DRUG: 
CERVICAL DILATATION AT THE TIME OF ADMINISTRATION OF THE 
DRUG: 
PULSE: 
BLOOD PRESSURE: 
FETAL HEART RATE : 
PAIN SCORE: 
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NEED FOR OXYTOCIN: 
INTERVAL FROM  ADMINSTRATION OF DRUG TO FULL DILATATION 
OF CERVIX: 
DURATION OF SECOND STAGE: 
MODE OF DELIVERY(INDICATION ): 
MODE OF PLACENTAL SEPERATION: 
POST PARTUM COMPLICATIONS: 
SIDE EFFECTS : 
NEONATAL OUTCOME: APGAR SCORE: 
BIRTH WEIGHT : 
NEED FOR NICU ADMISSION: 
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KEY WORDS IN MASTER CHART 
 
GA   -        Gestational Age 
Primi  -        Primigravida 
Multi  - Multigravida 
B   - Booked 
UB  - Booked outside 
LD  - Late deceleration 
Variable -      Variable deceleration 
Ur.ret  - Urinary retention 
motor B -  Motor block  
dural P -  Dural puncture 
n  -        Normal vaginal delivery 
cs  -        Caesarean section 
v  -        Vaccum assisted vaginal delivery 
F  -       Forceps assisted vaginal delivery  
arrest D -        Arrest of dilatation 
FM  -      Failed Maternal efforts 
Cpd  -        Cephalo pelvic disproportion 
non p  -        Non progression of labour 
m              -           Meconium stained liquour 
97 
 
distress -        Fetal distress 
failed I -        Failed Induction  
DTA  -        Deep Transverse Arrest 
Prolonged -        Prolonged labour  
S  -        spontaneous separation 
MRP  -        Manual Removal of Placenta  
INT(min) -        Interval from administration of drug to full dilatation in  
           minutes 
COMP -        Complications 
DEL  -        Delivery time 
2ND STG -        Second stage of labour duration 
MODE  D -        Mode of delivery 
INDICN -        Indication 
PLS  -        Mode of placental separation 
B  WT -        Birth weight 
 
Sl.N
o
I P NUM NAME AGE PARITY GA B/UB dilatation PULSE BP OB PAIN SCORE SEDATED OXYTOCICS INTERVAL CTG COMP INT(MIN) 2 ND STG MODE D INDICN PLS PPC B WT APGAR NICU
1 I10038654 RAJESHWARI 24 multi 40 B >3 cm<5 cm n n 20 ms 2 1 + 4 hrs nil nil 240 30 ms n nil s nil 3.2 kg 8/10,9/10 nil
2 I10039069 BAGYALAKSHMI 28 multi 39 B >3cm<5cm n n 15ms 2 2 + 3 hrs nil nil 180 30 ms n nil s nil 3.4 kg 8/10,9/10 nil
3 I10041106 VIJAYALAKSHM 26 primi 38+6 B >3cm<5cm n n 15ms 2 4 + 4 hrs nil nil 240 40 ms n nil s nil 2.8 kg 8/10,9/10 nil
4 I11041184 SARADHA 25 primi 38 +6 B >3 cm<5 cm n n 25ms 2 1 + nil nil nil nil nil cs m s nil 3.6 kg 8/10,9/10 nil
5 I11024181 VENI 23 primi 40+1 B >3cm<5cm n n 25ms 2 1 + nil nil dural P nil nil cs arrest D s nil 3.7 kg 7/10,8/10 adm
6 I11042176 PRIYA 26 primi 38+6 UB >3cm<5cm n n 15ms 2 1 + 4 hrs nil nil 240 40 ms v F M s nil 2.8 kg 8/10,9/10 nil
7 I11044491 DEEPA 30 multi 40+1 B >3 cm<5 cm n n 30 ms 2 1 + 4 hrs nil nil 240 30 ms n s nil 3 kg 8/10,9/10 nil
8 I11044694 RAJULA 30 primi 36+5 B >3cm<5cm n n 20 ms 2 1 + 5 hrs nil nil 300 30 ms v F M s nil 2.8 kg 8/10,9/10 nil
9 I12030867 NAVITHA 29 primi 39+6 B >3cm<5cm n n 35 ms 4 1 + nil nil nil nil nil cs non p s nil 3.2 kg 8/10,9/10 nil
10 I11046281 MUTHULAKSHMI 21 primi 39 UB >3 cm<5 cm n n 40 ms 4 1 + 5 hrs nil nil 300 30 ms v F M s nil 3.2 kg 8/10,9/10 nil
11 I11047635 NIVEDHITA 21 primi 39 B >3cm<5cm n n 25ms 4 1 + 5 hrs nil nil 300 30 ms v F M s nil 3.2 kg 8/10,9/10 nil
12 I11047992 SHANTHI 24 primi 39 B >3cm<5cm n n 40 ms 4 1 + nil nil motor B nil nil cs cpd s nil 3.8 kg 8/10,9/10 nil
13 I11042444 PADMAVATHY 24 primi 38+4 B >3 cm<5 cm n n 35 ms 8 2 + nil nil nil nil nil cs non p s nil 3 kg 8/10,9/10 nil
14 I11047004 SARANYA 23 primi 40+1 B >3cm<5cm n n 15ms 8 2 + 4 hrs nil nil 240 40 ms v F M s nil 3.1 kg 8/10,9/10 nil
15 I11005094 SHOBANA 30 primi 38+1 UB >3cm<5cm n n 40ms 8 2 + 3 hrs nil nil 180 30 ms v F M s nil 3.3 kg 8/10,9/10 nil
16 I10052062 MANJULA 23 primi 38 B >3 cm<5 cm n n 20 ms 8 2 + 3 hrs nil nil 180 30 ms v F M s nil 3.02 kg 8/10,9/10 nil
17 I11001451 RESHMI 25 primi 40 B >3cm<5cm n n 40 ms 2 4 + nil LD tachycardia nil nil cs distress s nil 2.9 kg 7/10,8/10 nil
18 I11000169 SARANYA 26 primi 40 B >3cm<5cm n n 15ms 2 1 + 3 hrs 30 msnil nil 210 30 ms n s nil 3 kg 8/10,9/10 nil
19 I11002267 GAJAPRIYA 25 primi 40 B >3 cm<5 cm n n 35 ms 2 1 + 3 hrs 30 msnil nil 210 30 ms n s nil 3.1 kg 8/10,9/10 nil
20 I11003187 MEENA 22 primi 40 B >3cm<5cm tachy hypotens30 ms 2 2 + nil nil FEVER nil nil cs m s nil 3.6 kg 8/10,9/10 nil
21 I11003801 AROKIAMARY 26 primi 39+6 UB >3cm<5cm n n 20 ms 2 2 + nil LD tachycardia nil nil cs distress s nil 3.2 kg 5/10,6/10 adm
22 I11008149 LATHA 22 primi 40 B >3 cm<5 cm n n 25ms 2 1 + 4 hrs nil nil 240 40 ms v F M s nil 2.8 kg 8/10,9/10 nil
23 I11005948 CHANDRAKALA 31 multi 40 UB >3cm<5cm n n 25ms 2 2 + nil variablenil nil nil cs distress s nil 3.3 kg 8/10,9/10 obs
24 I11008140 LATHA 31 primi 38 B >3cm<5cm n n 25ms 2 1 + 4 hrs nil nil 240 40 ms v F M s nil 3 kg 8/10,9/10 obs
25 I11008534 AKILA 21 primi 40+2 B 3cm n n 25ms 0 2 + nil nil nil nil nil cs m s nil 2.9 kg 8/10,9/10 nil
26 I11008149 LATHA 22 primi 40 B >3cm<5cm n n 25ms 0 1 + 3 hrs nil nil 180 40 ms v F M s nil 2.8 kg 8/10,9/10 nil
27 I11011606 JAYAGANDHI 30 multi 37+6 B >3cm<5cm n n 25ms 0 2 + 3 hrs variablenil 180 15 ms v distress s nil 3 kg 7/10,9/10 obs
28 I11012585 SENTHIL 28 primi 39 B >3 cm<5 cm n n 25ms 0 1 + 4 hrs LD nil 240 30 ms v distress s nil 3.6 kg 7/10,8/10 adm
29 I11015994 SHARANYA 26 primi 40 B >3cm<5cm n n 20 ms 2 2 + 4 hrs nil FEVER 240 40 ms v F M s nil 3.4 kg 8/10,9/10 nil
30 I11016178 NISHA 27 primi 40 UB >3cm<5cm n n 35 ms 2 2 + nil nil nil nil nil cs failed I s nil 3 kg 8/10,9/10 nil
31 I11014936 PRIYADHARSHINI 24 primi 40 B >3 cm<5 cm n n 40 ms 2 2 + 4 hrs nil nil 240 30 ms v F M s nil 3.6 kg 8/10,9/10 nil
32 I11015317 KOKILA 21 primi 38 B >3cm<5cm n n 35 ms 2 2 + nil LD dural P nil nil cs distress s nil 3.43 kg 7/10,7/10 nil
33 I11016236 MAYAVINODHINI 27 primi 38 B >3cm<5cm n n 15ms 2 2 + 4 hrs nil nil 240 30 ms n s nil 3.5 kg 8/10,9/10 nil
34 I11018218 SARANYA 20 primi 40+1 B >3 cm<5 cm n n 20 ms 4 4 + nil nil nil nil nil cs failed I s nil 3.5 kg 8/10,9/10 nil
35 I11021166 SHILPA 26 primi 40+4 UB >3cm<5cm n n 40 ms 4 4 + 5 hrs nil tachycardia 300 30 ms v F M s nil 3.2 kg 8/10,9/10 nil
36 I12028578 KANAGA 24 primi 40+2 UB 3cm n n 35 ms 6 1 + 3 hrs nil nil 180 30 ms n s nil 3 kg 8/10,9/10 nil
37 I12025297 NIRANJINI 19 primi 40 +1 B >3 cm<5 cm n n 20 ms 8 1 + 3 hrs nil nil 180 30  ms n s nil 3.5 kg 8/10,9/10 nil
38 I11021726 SHARMILA 26 primi 38 B >3cm<5cm n n 15ms 2 1 + 3 hrs 30 msnil nil 210 30 ms v F M mrp pph 3.6 kg 8/10,9/10 nil
39 I11026431 YAMUNARANI 31 multi 39+5 UB >3cm<5cm n n 25ms 2 1 + 2 hrs nil nil 120 30 ms v F M s nil 3 kg 8/10,9/10 nil
40 I11027072 RANJINI 26 primi 39 UB >3 cm<5 cm n n 20 ms 2 1 + 3 hrs 30 msnil nil 210 30 ms n s nil 3.2 kg 8/10,9/10 nil
41 I11028360 SATHYA 27 primi 40 UB >3cm<5cm n n 30 ms 2 1 + 4 hrs 30 msnil nil 270 30 ms n s nil 3.3 kg 8/10,9/10 nil
42 I11029177 SHYNI 28 primi 40 UB >3cm<5cm n n 45  ms 2 1 + nil nil nil nil nil cs non p s nil 3 kg 8/10,9/10 nil
43 I11032099 DHARANI 22 primi 39 B >3 cm<5 cm n n 15ms 2 1 + 3 hrs 30 msnil nil 210 30 ms v F M s nil 3.9 kg 8/10,9/10 nil
44 I11032142 SHALINI 24 primi 38 B >3cm<5cm n n 20 ms 2 1 + 4 hrs 30 msnil nil 270 30 ms v F M s nil 2.75 kg 8/10,9/10 nil
45 I11032951 SHIVANANDHINI 26 primi 39 B >3cm<5cm n n 25ms 2 1 + 4 hrs 30 msnil nil 270 30 ms v F M s nil 3 kg 8/10,9/10 nil
46 I11033204 SHALINI 24 primi 39+4 B >3 cm<5 cm n n 20 ms 2 1 + 4 hrs 30 msnil ur.ret 270 30 ms v F M s nil 2.9 kg 8/10,9/10 nil
47 I10038654 RAJESHWARI 28 primi 40 +1 UB >3cm<5cm n n 40 ms 0 1 + 4 hrs nil nil 240 30 ms n s nil 3.2 kg 8/10,9/10 nil
48 I12000893 SABEENA 25 primi 39 B >3cm<5cm n n 15ms 0 1 + 4 hrs nil nil 240 30 ms v F M s nil 3.2 kg 8/10,9/10 nil
49 I12031831 SUGANTHA 21 primi 40 UB >3 cm<5 cm n n 20 ms 0 1 + 5 hrs nil nil 300 15 ms n s nil 3.3 kg 8/10,9/10 nil
50 I12001086 ANITHA 22 primi 40 B >3cm<5cm n n 30 ms 0 1 + 4 hrs nil nil 240 20 ms n s nil 2.9 kg 8/10,9/10 nil
51 I12027591 NITHYA 23 primi 40+1 UB >3cm<5cm n n 20 ms 0 1 + 4 hrs nil ur.ret 240 20 ms n s nil 2.76 kg 8/10,9/10 nil
52 I12027470 MAHESHWARI 23 primi 39 B >3 cm<5 cm n n 15ms 0 4 + 4 hrs nil nil 240 30 ms v F M s nil 3.5 kg 8/10,9/10 nil
53 I12003407 KAVITHA 22 multi 40 UB >3cm<5cm n n 20 ms 0 1 + 3 hrs nil nil 180 1 hr F prolongeds pph 4 kg 8/10,8/10 nil
54 I12003626 MANIMEGALA 25 primi 39 B >3cm<5cm n n 30 ms 0 2 + 4 hrs nil nil 240 30 ms n s nil 3 kg 8/10,9/10 nil
55 I12001742 SIGAMANI 24 primi 40 B >3 cm<5 cm n n 30 ms 0 2 + 4 hrs nil nil 240 20 ms n s nil 3.3 kg 8/10,9/10 nil
56 I12004926 JASMIN 27 multi 39 B >3cm<5cm n n 20 ms 0 2 + 4 hrs nil nil 240 30 ms n s nil 3.6 kg 8/10,9/10 nil
57 I12004717 JEPSI 25 primi 40 B >3cm<5cm n n 25ms 4 2 + 4 hrs nil nil 240 30 ms n s nil 3.6 kg 8/10,9/10 nil
58 I12005567 KANAGA 24 primi 40+2 UB >3 cm<5 cm n n 35 ms 4 2 + 5 hrs nil ur.ret 300 30 ms n s nil 3 kg 8/10,9/10 nil
59 I12005445 JAYAPRIYA 22 multi 39 B >3cm<5cm n n 15 ms 4 2 + 7 hrs nil nil 420 20 ms n s nil 2.9 kg 8/10,9/10 nil
60 I12005619 GOMATHY 27 multi 37+6 B >3cm<5cm n n 35 ms 4 2 + 2 hrs nil nil 120 30 ms n s nil 3.2 kg 8/10,9/10 nil
61 I12005805 SUBHASHINI 28 multi 39 B 3cm n n 15ms 4 2 + 2 hrs 30 msnil nil 150 30 ms n s nil 3.5 kg 8/10,9/10 nil
62 I12005815 KRISHNAVENI 22 primi 39+6 B >3cm<5cm n n 20 ms 4 2 + 5 hrs nil head ache 300 30 ms n s nil 2.9 kg 8/10,9/10 nil
63 I12005873 LAKSHMI PRIYA 25 multi 39 B >3cm<5cm n n 20 ms 2 2 + 3 hrs 30 msnil nil 210 30 ms v F M s nil 3 kg 8/10,9/10 nil
64 I12006008 SUBBULAKSHMI 26 multi 38 B >3 cm<5 cm n n 40 ms 4 1 + 3 hrs nil nil 180 30 ms v F M s nil 3.2 kg 8/10,9/10 nil
65 I12005994 THENMOZHI 22 primi 37+6 B >3cm<5cm n n 40 ms 6 1 + 4 hrs nil nil 240 20 ms f F M s nil 3.7 kg 8/10,9/10 nil
66 I12007143 SOWMYASREE 26 primi 39 B >3cm<5cm n n 20 ms 8 1 + nil LD ur.ret nil nil cs distress s nil 3.3 kg 7/10,8/10 nil
67 I12007474 PREMALATHA 22 primi 39+2 B >3 cm<5 cm n n 25ms 2 1 + 4 hrs nil nil 240 30 ms v F M s nil 2.5 kg 8/10,9/10 nil
68 I12008272 JAMUNA 19 primi 40 UB >3cm<5cm n n 25ms 6 1 + 4 hrs 30 msnil nil 270 30 ms n s nil 3.1 kg 8/10,9/10 nil
69 I12009072 SABEENA 22 primi 39 UB >3cm<5cm n n 25ms 4 1 + 4 hrs nil nil 240 30 ms v F M mrp pph 4 kg 8/10,9/10 nil
70 I12010536 RATHI 22 primi 40 B >3 cm<5 cm n n 25ms 8 1 + 4 hrs 30 msnil nil 270 30 ms v F M s nil 3.5 kg 8/10,9/10 nil
71 I12010560 RAJESHWARI 25 multi 39 B >3cm<5cm n n 25ms 2 4 + 2 hrs nil nil 120 20 ms n s nil 3.8 kg 8/10,9/10 nil
72 I12010790 SAKHI 22 primi 39+3 B >3cm<5cm n n 25ms 2 2 + nil variableur.ret nil nil cs distress s pph 3.1 kg 8/10,8/10 nil
73 I12010913 MUBEENA 23 primi 39+2 B >3 cm<5 cm n n 25ms 4 2 + 5 hrs nil nil 300 30 ms n s nil 3.2 kg 8/10,9/10 nil
74 I12013607 HEMALATHA 26 multi 38 B >3cm<5cm n n 36 ms 4 2 + 4 hrs nil head ache 240 1 hr f prolongeds pph 3.9 kg 8/10,9/10 nil
75 I12026982 LEEMA 28 primi 38+3 B >3cm<5cm n n 15ms 4 2 + 4 hrs nil head ache 240 30 ms v F M s nil 2.9 kg 8/10,9/10 nil
76 I12024809 POORNIMA 26 multi 39 B >3 cm<5 cm n n 35 ms 6 2 + 3 hrs nil nil 180 20 ms n s nil 3.2kg 8/10,9/10 nil
77 I12026149 JAYA 20 primi B >3cm<5cm n n 15ms 2 2 + 4 hrs nil nil 240 20 ms n s nil 2.9 kh 8/10,9/10 nil
78 I12014685 MAHESHWARI 25 primi 39 UB >3cm<5cm n n 20 ms 6 2 + 4 hrs nil nil 240 30 ms n s nil 3.5 kh 8/10,9/10 nil
78 I12014911 MUTHULAKSHMI 22 primi 40 UB >3 cm<5 cm n n 20 ms 2 2 + nil nil ur.ret nil nil cs non p s nil 3.7 kg 8/10,9/10 nil
80 I12014899 VADIVUKARASI 30 multi 39+2 UB >3cm<5cm n n 25ms 4 2 + 3 hrs nil nil 180 30 ms n s nil 3.2 kg 8/10,9/10 nil
81 I12015935 MAHESHWARI 27 multi 39+6 B >3cm<5cm n n 30 ms 2 2 + nil nil nil nil nil cs non p s nil 3.3 kg 8/10,9/10 nil
82 I12015991 DIVYA 25 primi 40 B >3 cm<5 cm n n 20 ms 2 2 + nil nil nil nil nil cs non p s nil 4 kg 8/10,9/10 nil
83 I12018990 RATHIKA 24 primi 38 B >3cm<5cm n n 15ms 2 2 + nil nil nil nil nil cs arrest d s nil 3.8 kg 6/10,7/10 adm
84 I12019012 KAYALVIZHI 29 multi 37+6 B >3cm<5cm n n 15ms 6 2 + 3 hrs nil nil 180 30 ms n s nil 2.9 kg 8/10,9/10 nil
85 I12020380 HEMAMBIGAI 24 multi 38 B >3 cm<5 cm n n 15ms 6 2 + 3 hrs nil nil 180 30 ms n s nil 2.7 kg 8/10,9/10 nil
86 I11047004 SARANYA 22 primi 38 B >3cm<5cm n n 15ms 10 2 + 5  hrs nil motor B 300 20 ms n s nil 3.5 kg 8/10,9/10 nil
87 I12022886 ANKITHA 22 primi 38+1 B >3cm<5cm n n 30 ms 4 2 + 5 hrs nil nil 300 20 ms v F M s nil 3.3 kg 8/10,9/10 nil
88 I12031831 REVATHY 23 primi 40 B >3 cm<5 cm n n 20 ms 2 2 + 4  hrs nil nil 240 20 ms n mrp pph 3 kg 8/10,9/10 nil
89 I12026745 KARUNYA 28 primi 37+6 B >3cm<5cm n n 25ms 2 2 + nil nil nil nil nil cs failed I s nil 2.5 kg 8/10,9/10 nil
90 I12024972 SANKARI 22 primi 40 B >3cm<5cm n n 40 ms 2 2 + nil nil ur.ret nil nil cs DTA s nil 2.9 kg 6/10,7/10 adm
91 I12026982 LEEMA 28 primi 38+3 B >3 cm<5 cm n n 15ms 2 2 + 5 hrs nil nil 300 30 ms v F M s nil 2.9 kg 8/10,9/10 nil
92 I12026909 SUDHA 22 primi 37+3 B >3cm<5cm n n 30 ms 6 2 + 5 hrs nil nil 300 30 ms v F M s nil 3.1 kg 8/10,9/10 nil
93 I12027921 SASIKALA 27 primi 40 B >3cm<5cm n n 25ms 4 2 + nil nil nil nil nil cs cpd s nil 3.5 kg 8/10,9/10 nil
94 I12029270 SHRUTHI 22 primi 39+6 B >3 cm<5 cm n n 30 ms 4 2 + 4 hrs nil tachycardia 240 1 hr 30 ms cs DTA s nil 3.1 kg 7/10,8/10 obs 
95 I12027068 KAVITHA 30 primi 39 B >3cm<5cm n n 15ms 8 2 + 4 hrs nil nil 240 1 hr 30 ms cs DTA s nil 3.3 kg 8/10,9/10 nil
96 I12032558 PRIYADHARSHINI 26 primi 39+6 B >3cm<5cm n n 40 ms 4 2 + 5 hrs nil head ache 300 20 ms v F M s nil 3 kg 8/10,9/10 nil
97 I12030867 MRITHULA 26 primi 38 UB >3 cm<5 cm n n 25ms 8 2 + 5 hrs nil ur.ret 300 30 ms v F M s nil 3.6 kg 8/10,9/10 nil
98 I12031134 KRISHNAKUMARI 25 primi B >3cm<5cm n n 40 ms 2 2 + 5 hrs nil nil 300 30 ms v F M s nil 3.5 kg 8/10,9/10 nil
99 I11041184 SARADHA 26 primi 37 UB >3cm<5cm n n 30 ms 2 2 + nil nil ur.ret nil nil cs non p s nil 2.9 kg 8/10,9/10 nil
100 I12031831 SUGANTHA 25 primi 38+6 B >3 cm<5 cm n n 25ms 2 2 + 5 hrs nil nil 300 30 ms n s nil 3.2 kg 8/10,9/10 nil
101 I12004583 SANGEETHA 24 primi 39 +2 B >3cm<5cm n n nil 8 4 +  5 hrs 30 msnil nil 330 30 ms v F M s nil 3.3 kg 8/10,9/10 nil
102 I12004190 PARVEENA 26 multi 38 B >3cm<5cm n n nil 10 4 + nil LD nil nil nil cs distress s nil 2.9 kg 7/10,8/10 nil
103 I12004270 NANDHINI 23 primi 40 B >3 cm<5 cm n n nil 8 4 + 5 hrs nil nil 300 30 ms n s nil 3.6 kg 8/10,9/10 nil
104 I12004638 SAJEENA 20 primi 38+6 B >3cm<5cm n n nil 10 4 + 5 hrs 30 msnil nil 330 30 ms n s nil 2.9 kg 8/10,9/10 nil
105 I12004182 RADHA 29 multi 37 B >3cm<5cm n n nil 8 4 + nil nil nil nil nil cs non p mrp pph 3.9 kg 6/10,7/10 nil
106 I12004950 PANKAJ 30 multi 38 UB >3 cm<5 cm n n nil 10 4 + 4 hrs nil vomiting 240 20 ms n s nil 3.1 kg 8/10,8/10 nil
107 I12005040 JANSI 22 primi 39 B >3cm<5cm n n nil 8 2 + nil variablenil nil nil cs DTA s nil 3.2kg 6/10,7/10 adm
108 I12005394 RAMYA 24 primi 40 B >3cm<5cm n n nil 8 1 + 5 hrs nil nil 300 30 ms n mrp nil 2.9 kh 8/10,9/10 nil
109 I12005186 NIRANJINI 19 primi 40 +1 B >3 cm<5 cm n n nil 8 1 + 5 hrs nil nil 300 30  ms n s nil 3.5 kh 8/10,9/10 nil
110 I12005608 MANJULA 27 primi 40 UB >3cm<5cm n n nil 8 1 + 4 hrs nil nil 240 20 ms n s nil 3.7 kg 8/10,9/10 nil
111 I12005567 KAVIPRIYANKA 24 primi 39 UB >3cm<5cm n n nil 8 2 + 4 hrs nil nil 240 20 ms n s nil 3.2 kg 8/10,9/10 nil
112 I12005738 REVATHY 29 primi 39+3 UB >3 cm<5 cm n n nil 10 2 + nil nil vomiting nil nil cs cpd s pph 4 kg 8/10,9/10 nil
113 I12005687 POORNIMA 32 multi 39+6 B >3cm<5cm n n nil 10 2 + 4 hrs nil nil 240 20 ms n s nil 3.9 kg 8/10,9/10 nil
114 I12006012 GEETHA 28 primi 40 B >3cm<5cm n n nil 10 2 + 4 hrs nil nil 240 60 ms v prolongedmrp pph 3.8 kg 8/10,8/10 nil
115 I12006124 KAVITHA 25 primi 40 +2 B >3 cm<5 cm n n nil 10 2 + 4 hrs 30 msnil nil 270 30 ms n s nil 2.9 kg 8/10,9/10 nil
116 I12006845 RUBY 32 multi 39 B >3cm<5cm n n nil 10 4 + nil LD vomiting nil nil cs distress s nil 2.7 kg 7/10,8/10 obs 
117 I12007259 AMBIKA 28 primi 38 B >3cm<5cm n n nil 10 4 + 5 hrs nil nil 300 20 ms n s nil 3.5 kg 8/10,9/10 nil
118 I12007531 GOMATHY 19 primi 38+4 B >3 cm<5 cm n n nil 8 4 + 5 hrs nil nil 300 30 ms n s nil 3.3 kg 8/10,9/10 nil
119 I12009062 SINDHU 20 primi 40 UB >3cm<5cm n n nil 6 4 + 4 hrs nil nil 240 30 ms n s nil 3 kg 8/10,9/10 nil
120 I12009228 SUDHA 22 primi 39 B >3cm<5cm n n nil 8 4 + nil nil nil nil nil cs cpd s nil 2.9 kg 8/10,9/10 nil
121 I12009171 VIJAYALAKSHM 27 primi 38+5 B >3 cm<5 cm n n nil 8 4 + 4 hrs nil vomiting 240 40 ms n s nil 2.8 kg 8/10,9/10 nil
122 I12011372 VANITHA 29 primi 39 B >3cm<5cm n n nil 8 4 + 5 hrs nil nil 300 15 ms n s nil 3 kg 8/10,8/10 nil
123 I12011283 SUGANTHI 28 multi 37 UB >3cm<5cm n n nil 86 4 + 3 hrs nil nil 180 15 ms n s nil 3.6 kg 8/10,9/10 nil
124 I12011389 ARASI 29 multi 37+6 UB >3 cm<5 cm n n nil 6 4 + 4 hrs nil nil 240 30 ms n s nil 3.4 kg 8/10,9/10 nil
125 I12014340 SHEEBA 23 primi 40 UB >3cm<5cm n n nil 6 4 + 4 hrs nil nil 240 60 ms v F M s nil 3 kg 8/10,9/10 nil
126 I12014143 CATHERIN 23 primi 40+1 B >3cm<5cm n n nil 6 4 + nil LD nil nil nil cs distress s nil 3.6 kg 6/10,7/10 adm
127 I12014449 CHITHRA 26 primi 40 B 3cm n n nil 6 4 + 4 hrs nil nil 240 15 ms n s nil 3.43 kg 8/10,9/10 nil
128 I12014420 SUJI 27 primi 40+3 B >3cm<5cm n n nil 10 4 + 4 hrs nil nil 240 15 ms n s nil 3.6 kg 8/10,9/10 nil
129 I12014716 MAHALAKSHMI 29 multi 39+6 B >3cm<5cm n n nil 10 4 + 4 hrs 30 msnil nil 270 30 ms n s nil 3.5 kg 8/10,9/10 nil
130 I12017425 SWETHA 26 primi 39 B >3 cm<5 cm n n nil 8 4 + 5 hrs nil nil 300 60 ms v F M mrp nil 3.2 kg 8/10,9/10 nil
131 I12016312 POORNIMA 21 primi 39+4 B >3cm<5cm n n nil 8 4 + 4 hrs 30 msnil vomiting 270 30 ms n s nil 3.5 kg 8/10,9/10 nil
132 I12017328 NELUFER 32 multi 38 B >3cm<5cm n n nil 10 4 + 3 hrs nil nil 180 15 ms n s nil 2.9 kg 8/10,9/10 nil
133 I12020685 SATHYA 24 primi 39+2 UB >3 cm<5 cm n n nil 8 2 + nil nil nil nil nil cs arrest d s nil 3.6 kg 7/10,7/10 adm
134 I12021183 MUTHULAKSHMI 23 primi 39 UB >3cm<5cm n n nil 8 2 + nil variablenil nil nil cs distress s nil 3 kg 8/10,9/10 nil
135 I12023610 NABEESHA 29 multi 38 B >3cm<5cm n n nil 8 2 + 4 hrs nil nil 240 15 ms n s nil 2.9 kg 8/10,9/10 nil
136 I12026975 DHIVYA 24 primi 39+3 B >3 cm<5 cm n n nil 10 2 + 5 hrs nil nil 300 30 ms n s nil 3.2 kg 8/10,9/10 nil
137 I12026852 PAVITHRA 29 multi 39+6 B >3cm<5cm n n nil 4 2 + 4 hrs 30 msnil vomiting 270 30 ms n s nil 3 kg 8/10,9/10 nil
138 I12027068 KAVITHA 32 multi 40 B >3cm<5cm n n nil 4 2 + 4 hrs nil vomiting 240 30 ms n s nil 3.9 kg 8/10,9/10 nil
139 I12027112 RADHAMMAL 23 primi 40 +2 B >3 cm<5 cm n n nil 4 2 + nil ld nil nil nil cs distress s pph 3.2 kg 7/10,7/10 adm
140 I12027116 REVATHY 22 primi 39 B >3cm<5cm n n nil 8 2 + 4 hrs 30 msnil nil 270 30 ms n s nil 3.4 kg 8/10,9/10 nil
141 I12026995 NAGOMI 26 primi 38 B >3cm<5cm n n nil 8 2 + 5 hrs 30 msnil nil 330 30 ms n s nil 2.8 kg 8/10,9/10 nil
142 I12027009 VINITHA 28 primi 38+4 B >3 cm<5 cm n n nil 8 2 + 4 hrs nil nil 240 20 ms n s nil 3.6 kg 8/10,9/10 nil
143 I12027184 PADMAVATHY 26 primi 40 B >3cm<5cm n n nil 10 2 + nil nil nil nil nil cs cpd s nil 3.7 kg 8/10,8/10 nil
144 I12027414 HARI PRIYA 29 primi 39 B >3cm<5cm n n nil 10 2 + 5 hrs nil nil 300 30 ms v F M s nil 2.8 kg 8/10,9/10 nil
145 I12027417 SASIKALA 20 primi 38+5 B >3 cm<5 cm n n nil 6 2 + 6 hrs variablenil 360 30  ms n s nil 3 kg 7/10,8/10 obs 
146 I12027367 ANITHA 22 primi 39 B >3cm<5cm n n nil 8 2 + 4 hrs nil nil 240 20 ms n s nil 2.8 kg 8/10,9/10 nil
147 I12027530 ESTHER 27 multi 37 B >3cm<5cm n n nil 8 2 + nil variablevomiting nil nil cs distress s nil 3.2 kg 6/10,7/10 adm
148 I12027335 SADHANA 19 primi 37+6 B >3 cm<5 cm n n nil 8 2 + nil nil nil nil nil cs arrest d s nil 3.2 kg 8/10,9/10 nil
149 I12027451 NANDHINI 30 multi 39 B >3cm<5cm n n nil 8 2 + 4 hrs nil nil 240 20 ms n s nil 3.2 kg 8/10,9/10 nil
150 I12027591 JAYAMANI 20 primi 40+1 B >3cm<5cm n n nil 8 2 + 4 hrs nil vomiting 240 60 ms n s nil 3.8 kg 8/10,9/10 nil
151 I12027470 SAROJINI 26 multi 39 B >3 cm<5 cm n n nil 8 2 + 4 hrs 30 msnil nil 270 30 ms n s nil 3 kg 8/10,8/10 nil
152 I12027772 KOWSALYA 26 primi 40+3 B >3cm<5cm n n nil 10 2 + 4 hrs nil vomiting 240 20 ms n s nil 3.1 kg 8/10,9/10 nil
153 I12027999 KARTHIKA 22 primi 39+6 UB >3cm<5cm n n nil 6 2 + nil nil vomiting nil nil cs cpd s nil 3.3 kg 8/10,9/10 nil
154 I12027795 PECHIAMMAL 20 primi 39 B >3 cm<5 cm n n nil 8 2 + 4 hrs nil nil 240 30 ms v distress s nil 3.02 kg 7/10,8/10 obs 
155 I12027932 NAGARATHINAM 31 multi 39+4 B >3cm<5cm n n nil 8 2 + 3 hrs nil vomiting 180 30 ms n mrp pph 2.9 kg 6/10,7/10 adm
156 I12028166 LAKSHMI PRIYA 22 primi 40 B >3cm<5cm n n nil 8 2 + 4 hrs nil nil 240 30 ms n s nil 3 kg 8/10,9/10 nil
157 I12028175 ESWARI 19 primi 39+2 B >3 cm<5 cm n n nil 8 2 + 4 hrs LD nil 240 40 ms v distress s nil 3 kg 7/10,8/10 adm
158 I12028172 MALARVIZHI 23 primi 39 B >3cm<5cm n n nil 8 2 + 4 hrs nil nil 240 15 ms n s pph 3.6 kg 8/10,9/10 nil
159 I12028186 THILAGAVATHY 23 multi 39 B >3cm<5cm n n nil 10 2 + 3 hrs nil nil 180 15 ms n s nil 3.2 kg 8/10,9/10 nil
160 I12027935 SANGEETHA 27 primi 38 B >3 cm<5 cm n n nil 8 2 + 4 hrs nil vomiting 240 30 ms f F M s pph 3.3 kg 8/10,9/10 nil
161 I12028347 DEEPA 27 primi 39 B >3cm<5cm n n nil 8 2 + 3 hrs nil nil 180 60 ms n s nil 3.3 kg 8/10,9/10 nil
162 I12028411 MAHESHWARI 21 primi 40 UB >3cm<5cm n n nil 8 2 + nil variablenil nil nil cs distress s nil 3 kg 7/10,8/10 adm
163 I12028709 ANANTHI 25 primi 40 +1 B >3 cm<5 cm n n nil 6 2 + nil nil vomiting nil nil cs m s nil 2.9 kg 7/10,7/10 adm
164 I12028721 SATHYA 27 primi 40 B >3cm<5cm n n nil 6 4 + nil nil vomiting nil nil cs m s nil 2.8 kg 8/10,8/10 nil
165 I12028811 VIJAYALAKSHM 21 primi 39 B >3cm<5cm n n nil 6 4 + nil variablenil nil nil cs distress s nil 3 kg 8/10,9/10 nil
166 I12028747 KOPAMMAL 30 primi 39+3 UB >3 cm<5 cm n n nil 10 4 + 3 hrs LD nil 180 40 ms v distress s nil 3.6 kg 6/10,7/10 adm
167 I12028673 SANGEETHA 25 primi 39+6 UB >3cm<5cm n n nil 10 3 + 4 hrs nil nil 240 15 ms n s nil 3.4 kg 8/10,9/10 nil
168 I12028796 USHA 24 primi 40 UB >3cm<5cm n n nil 10 3 + 3 hrs nil vomiting 180 15 ms v F M s nil 3 kg 8/10,9/10 nil
169 I12028825 ARULVANI 20 primi 40 +2 B 3cm n n nil 8 3 + 4 hrs nil nil 240 30 ms n s nil 3 kg 7/10,9/10 nil
170 I12028578 NIRMALA 20 primi 39 B >3cm<5cm n n nil 8 3 + 4 hrs nil nil 240 60 ms v F M s nil 3.2 kg 7/10,9/10 nil
171 I12025297 RADHA 26 primi 39 B >3cm<5cm n n nil 8 3 + 4 hrs nil vomiting 240 30 ms n s nil 3.2 kg 8/10,9/10 nil
172 I12025303 PRAVEENA 34 multi 39 B >3 cm<5 cm n n nil 8 3 + 4 hrs 30 msnil nil 270 30 ms v F M s nil 3.3 kg 8/10,9/10 nil
173 I12025319 PRIYA 30 primi 39+6 B >3cm<5cm n n nil 10 3 + nil LD nil nil nil cs distress s nil 2.9 kg 7/10,7/10 adm
174 I12025042 SUBHASHINI 35 multi 37 B >3cm<5cm n n nil 8 3 + 4 hrs nil nil 240 30 ms n s nil 3.6 kg 8/10,9/10 nil
175 I12025246 SUDHA 20 primi 37+3 B >3 cm<5 cm n n nil 8 3 + 4 hrs 30 msnil vomiting 270 30 ms n s nil 2.9 kg 8/10,9/10 nil
176 I12025357 VALLI 21 primi 37+5 B >3cm<5cm n n nil 8 3 + nil nil nil nil nil cs non p mrp pph 3.9 kg 8/10,9/10 nil
177 I12025374 MEKALA 23 primi 39+6 UB >3cm<5cm n n nil 8 3 + 3 hrs nil nil 180 20 ms n s nil 3.1 kg 8/10,9/10 nil
178 I12025481 VIJAYALAKSHM 26 primi 40 B >3 cm<5 cm n n nil 8 3 + nil variablevomiting nil nil cs DTA mrp nil 3.2kg 7/10,8/10 obs 
179 I12025586 RAMYA 24 primi 40 B >3cm<5cm n n nil 10 3 + 4 hrs nil nil 180 30 ms n s nil 2.9 kh 8/10,9/10 nil
180 I12025321 REMY 20 primi 40+1 B >3cm<5cm n n nil 10 3 + 5 hrs nil nil 300 30  ms n s nil 3.5 kg 8/10,9/10 nil
181 I12025695 THASEENA 21 primi 40+3 UB >3 cm<5 cm n n nil 10 3 + 3 hrs nil vomiting 180 30 ms n s nil 3.7 kg 8/10,9/10 nil
182 I12025456 DEVIKA 23 primi 39+6 UB >3cm<5cm n n nil 10 3 + 3 hrs nil vomiting 180 20 ms n s nil 3.2 kg 8/10,9/10 nil
183 I2025604 JAYALAKHMI 26 primi 39+6 B >3cm<5cm n n nil 10 3 + nil nil nil nil nil cs cpd s pph 4 kg 8/10,9/10 nil
184 I12025497 SABEENA 27 primi 39+2 B >3 cm<5 cm n n nil 8 3 + 4 hrs nil vomiting 240 30 ms n s nil 2.9 kg 8/10,9/10 nil
185 I12025792 AMBIKA 21 multi 39+3 B >3cm<5cm n n nil 8 3 + 4 hrs nil nil 240 60 ms v prolongedmrp pph 3.8 kg 7/10,8/10 adm
186 I12025337 RANI 27 primi 39+5 B >3cm<5cm n n nil 8 3 + 4 hrs 30 msnil nil 270 30 ms n s nil 2.9 kg 8/10,8/10 nil
187 I12025798 VISHNUPRIYA 23 primi 40+1 B >3 cm<5 cm n n nil 8 3 + nil LD vomiting nil nil cs distress s nil 2.7 kg 6/10,7/10 adm
188 I12025662 PUNITHA 26 primi 39 B >3cm<5cm n n nil 10 3 + 4 hrs nil nil 240 20 ms n s nil 3.5 kg 8/10,9/10 nil
189 I12025881 SHOBANA 37 multi 40 B >3cm<5cm n n nil 10 3 + 4 hrs nil vomiting 240 30 ms n s nil 3.3 kg 8/10,9/10 nil
190 I12025911 KARTHIKA 31 multi 39+6 B >3 cm<5 cm n n nil 10 3 + 3 hrs nil nil 180 30 ms n s nil 3 kg 8/10,9/10 nil
191 I12025967 PADMAVATHY 25 primi 39 UB >3cm<5cm n n nil 8 3 + nil nil vomiting nil nil cs cpd s nil 3.9 kg 8/10,9/10 nil
192 I12025754 MAHESHWARI 22 primi 39+4 B >3cm<5cm n n nil 8 3 + 3 hrs nil nil 180 40 ms n s nil 2.8 kg 8/10,9/10 nil
193 I12025754 MAHESHWARI 20 primi 40 B >3 cm<5 cm n n nil 8 3 + 4 hrs nil vomiting 240 15 ms n s nil 3 kg 8/10,9/10 nil
194 I12076012 MUTHUPECHI 31 multi 39+2 B >3cm<5cm n n nil 8 3 + 3 hrs nil nil 180 15 ms n s nil 3.6 kg 8/10,8/10 nil
195 I1202597 KRISHNAPRIYA 22 primi 39 UB >3cm<5cm n n nil 10 3 + 4 hrs nil vomiting 240 30 ms n s nil 3.4 kg 8/10,9/10 nil
196 I12028609 YOGESWARI 19 primi 39 UB 3cm n n nil 8 3 + 4 hrs nil nil 240 20 ms n s nil 3.2 kg 8/10,9/10 nil
197 I12024809 DEEPA 23 primi 38 UB 3cm n n nil 8 3 + nil variablevomiting nil nil cs distress s nil 3.3 kg 7/10,8/10 obs 
198 I12026149 SAINABA 23 multi 40 UB >3cm<5cm n n nil 10 3 + 3 hrs nil vomiting 180 15 ms n s nil 3.5 kg 8/10,9/10 nil
199 I12025858 AYESHA 27 primi 40+3 UB >3 cm<5 cm n n nil 8 3 + 4 hrs nil vomiting 240 30 ms n s nil 3.8 kg 8/10,9/10 nil
200 I12026264 SOWNDARYA 27 primi 40+1 B >3cm<5cm n n nil 10 3 + 4 hrs nil nil 240 20 ms n s nil 3 kg 8/10,9/10 nil
